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Introduction
 4
Dementia 
 
Dementia is a chronic clinical syndrome characterized by a progressive deterio-
ration of capabilities that affects a person’s ability to function independently. 
Symptoms of dementia are the loss of memory, judgement and reasoning, 
changes in mood and behaviour, and progressive difficulties in the performance 
of complex daily activities such as managing medication or finances and later 
on also in simple tasks performances such as eating or toileting.1  
Worldwide an estimated 24 million people suffered from dementia in 2001. It is 
predicted that this number will rise to over 80 million people by 2040.2 The num-
bers of people with dementia are predicted to be 16 million in the year 2050 in 
Europe3, 2.3 million in Germany4, and 0.5 million in The Netherlands.5 In Ger-
many, the majority of people with dementia (60%) live in the community and 
receive care by their family members.6 Direct and indirect dementia costs are 
estimated to be 43,767 Euro per year and patient, divided into 2 % medical 
costs, 30 % nursing care costs and 68 % costs borne by the patients’ families7. 
About one third of patients with mild or moderate dementia receive informal 
care of 4 to 10 h per day and one third more than 10 h per day.8 The deteriora-
tion of patients’ daily functioning caused by deficits in cognition and affective 
behaviour is an increasing burden for the family caregiver.9-11 
So far, neither an effective causal treatment nor disease-modifying drugs are 
available for the treatment of dementia. The systematic review of Luijpen et al.12 
concluded that improvements in cognition and affective behaviour by non-
pharmacological interventions (d = 0.32) and by cholinesterase inhibitors (d = 
0.31) were of similar effect-size. However, daily functioning was not subject of 
the analysis. The review of Smits et al.13 on combined intervention programmes 
identified some studies demonstrating positive impact on the mental health of 
patients and carers. But no consistent positive effects on the patient’s activities 
of daily living could be found. A synopsis of four systematic reviews analysing 
73 RCTs on the efficacy of pharmacological and psychosocial interventions re-
garding everyday functioning in dementia concluded that positive effects of 
drugs on activities of daily living (ADL) are small (pooled effect sizes < 0.28) 
and heterogeneous regarding safety and that high quality multi-centre random-
ised trials on the effects of psychosocial interventions are missing14. In sum-
mary, literature shows consistent small effects of drugs regarding patient’s daily 
functioning and inconsistent effects with largely varying outcomes and lack of 
high quality trials for psycho-social interventions.  
 
 
Occupational Therapy in Dementia 
 
Guidelines for dementia management recommend occupational therapy.15-17 
Occupational therapy specialises in supporting independence in ADL and uses 
a complex approach including activity simplification, environmental modification, 
adaptive aids, problem-solving strategies, skill training and carer training.18 19 
The assumed mechanism of how occupational therapy affects the daily func-
tioning of people with dementia is corresponding with the bio-psycho-social 
health model of the World Health Organization. The negative impact of cognitive 
deficits on activities can be diminished by improving the patient's physical and 
social environment and by tailoring the intervention to the patient's capability.20 
The task performance of people with dementia can be improved by reducing 
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distraction and arranging clear structures in the physical environment.21 Re-
search on caregiver interventions provides evidence that educational and psy-
chosocial approaches targeting at the optimisation of the social environment 
have the potential to delay nursing home placement.22-24 Tailoring the activities 
planned to patients' capability may enhance activity engagement and reduce 
challenging behaviour.25 Parker et al.26 advocated well-designed multi-
component psycho-social interventions directed to both patients and carers and 
encouraging the carer’s active participation. 
In the absence of systematic reviews on community occupational therapy for 
people with Alzheimer’s disease, evidence is based on the work of two research 
groups who conducted mono-centre RCTs in this subject. The USA study group 
found beneficial effects on patients’ challenging behaviour.25 27 28 The Dutch 
group also found positive effects on patients’ ADL, mood, health status and 
quality of life and on carers’ sense of competence, mood, quality of life and 
costs of informal care.29-32 The Dutch programme demonstrated promising posi-
tive effects on daily functioning and costs of care and was the starting point of a 
research proposal from the University of Freiburg, Germany, which was funded 
by the German Federal Ministry of Health.  
The Dutch Community Occupational Therapy in Dementia programme (COTiD) 
aims at the improvement of daily functioning of both the patients and their pri-
mary caregivers.33-35 The treatment of the patient focuses on enabling the suc-
cessful performance of highly meaningful daily activities. The intervention focus 
for the caregiver is on enhancement of successful interaction with the person 
with dementia by improving the caregiver’s skills in communication, supervision 
and problem solving. A manual comprising a detailed description of the inter-
vention is available.33 35 The process, in which this guideline for the treatment of 
older people with cognitive impairments has been developed, was evaluated 
systematically over the last ten years. This process included a literature review, 
theoretical modelling, an advisor panel of international experts, draft manuals, 
pilot testing in practice, case study analyses, a pilot study and a mono-centre 
RCT on effectiveness and on cost-effectiveness.29-34  
 
 
Cross-national transfer  
 
The planned transfer included changes in three ways. (1) The transfer across 
nations from the Netherlands to Germany. (2) Changes in trial design from 
mono-centre waiting control group design with 12 week follow up to a multi-
centre active control group design with 26 weeks follow up period. (3) A shift in 
the expertise of the interventionists from two highly motivated experts with sev-
eral years of treatment experience to 14 newly introduced therapists working in 
routine care setting. 
Ad (1): In Europe, cross-national dementia research is recently concerned with 
the issues of timely recognition and diagnosis and with cross-sectional compari-
sons of care status.36-39 International literature on the cross-national transfer of 
psychosocial interventions in dementia is scarce.40 The only multi-centre RCT 
analysing cross-national differences in the impact of a psychosocial intervention 
in dementia found that changes in the treatment group did not significantly differ 
among the study sites in New York, Manchester and Sydney.41 Guidelines on 
successful cross-national transfer of complex interventions in dementia are 
missing. However, the European group “Early detection and timely INTERven-
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tion in DEMentia” (www.interdem.org) achieved consensus on a set of meas-
urement instruments to be used in international psychosocial intervention re-
search. Our project was supported by members of the INTERDEM group and 
carefully considered their recommendations on the use of instruments. 
Ad (2): The shift from a specific mono-centre design to a multi-site trial in seven 
different regions with less restrictive exclusion criteria represents the step from 
an explanatory RCT on efficacy to a pragmatic RCT on effectiveness. In this 
step we very closely followed the recommendations of the CONSORT and 
Practihc groups42, in order to avoid any poor planning and reporting of our 
pragmatic RCT design. Furthermore, we performed the power calculation very 
conservatively to address the expectation of effect size reduction in such a 
pragmatic setting.  
Ad (3): From the perspective of our newly introduced trial interventionists, the 
application of the Dutch COTiD programme can be considered as uptake of an 
innovation. Consequently, we brought our project plan in line with the guidance 
of implementation research as far as possible within the given frame conditions. 
According to the defined ADAPTE process43, we (a) determined our research 
question, (b) searched and screened structured and manualised programmes of 
community occupational therapy in dementia, (c) systematically assessed the 
identified guidelines regarding currency, consistency and applicability and (d) 
decided for the COTiD. However, we could not realize all recommended steps. 
We missed the customisation of the guideline to the different local contexts of 
the seven study sites and the incorporation of the interventionists who would 
use the guideline in the process of guideline assessment. This could not be re-
alized otherwise, because the trial had to be planned before all interventionists 
at the different study sites could be named. However, we have arranged that 
occupational therapists translate the manual from Dutch to German and thus 
avoid misunderstandings in taxonomy. 
 
 
Objective and outline of this thesis 
 
The primary aim of the research project was to determine whether the Dutch 
COTiD programme still has positive effects on patients’ daily functioning when 
occupational therapists who were newly introduced in this complex psychoso-
cial intervention apply it in a routine care context of another country. The PhD 
thesis is a synopsis of five publications reporting the background, objectives, 
methods and results of a pragmatic multi-centre RCT as well as the accompa-
nying cross-national process evaluation and trans-cultural validation efforts of 
three measurement instruments. 
 
Chapter 2 presents a randomised controlled trial at seven German study sites 
testing the hypothesis that the Dutch ten-session Community Occupational 
Therapy in Dementia Programme would significantly improve the daily function-
ing of people with mild or moderate dementia, more so than a one-session 
Community Occupational Therapy Consultation. 
 
Chapter 3 describes the process evaluation exploring possible bias within the 
German study and differences between the Dutch and German RCT. 
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Chapter 4 reports the translation process and the construct and concurrent va-
lidity of the Interview for Deterioration in Daily Living Activities in Dementia. 
 
Chapter 5 provides results on the test consistency and inter-rater agreement of 
the Perceive, Recall, Plan and Perform Assessment. 
 
Chapter 6 describes the construct and concurrent validity of the Dementia Qual-
ity of Life Instrument in patients with mild to moderate dementia. 
 
Chapter 7 discusses the implications of the findings for future practice and re-
search regarding to cross-national transfers of complex intervention pro-
grammes. 
 
 
References 
 
1 Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. Lancet 2006, 368(9533):387-403. 
2 Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’s disease. The Lancet 
2011;377:1019-31. 
3 Wancata J, Musalek M, Alexandrowicz R, Krautgartner M: Number of dementia sufferers in Europe be-
tween the years 2000 and 2050. Eur Psychiatry 2003, 18:306-313. 
4 Bickel H: Epidemiologie und Gesundheitsökonomie. In Demenzen. Referenzreihe Neurologie Edited by: 
Wallesch CW, Förstl H. Stuttgart: Thieme Verlag; 2005:1-15. 
5 Health Council of the Netherlands. Dementia. The Hague: Health Council of the Netherlands 2002. (In 
Dutch.) 
6 Robert Koch-Institut: Gesundheitsberichterstattung des Bundes, Heft 28 Altersdemenz Robert Koch-
Institut. Berlin; 2005. 
7 Hallauer JF et al. Gesundheitsökonomie und Qualitätsmanagement 2000, 5:73–79. 
8 Georges J, Jansen S, Jackson J, Meyrieux A, Sadowska A, Selmes M. Alzheimer's disease in real life--
the dementia carer's survey. Int J Geriatr Psychiatry. 2008 May;23(5):546-51. 
9 Ernst RL, Hay JW, Fenn C, Tinklenberg J, Yesavage JA. Cognitive function and the costs of Alzheimer 
disease. An exploratory study. Arch Neurol. 1997 Jun;54(6):687-93. 
10 Hux MJ, O'Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S. Relation between severity of Alz-
heimer's disease and costs of caring. CMAJ. 1998 Sep 8;159(5):457-65. 
11 Schneider J, Murray J, Banerjee S, Mann A. EUROCARE: a cross-national study of co-resident spouse 
carers for people with Alzheimer's disease: I—Factors associated with carer burden. Int J Geriatr 
Psychiatry. 1999 Aug;14(8):651-61. 
12 Luijpen MW, Scherder EJ, Van Someren EJ, Swaab DF, Sergeant JA. Non-pharmacological interven-
tions in cognitively impaired and demented patients--a comparison with cholinesterase inhibitors. 
Rev Neurosci. 2003;14(4):343-68. 
13 Smits CH, de Lange J, Dröes RM, Meiland F, Vernooij-Dassen M, Pot AM. Effects of combined interven-
tion programmes for people with dementia living at home and their caregivers: a systematic review. 
Int J Geriatr Psychiatry. 2007 Dec;22(12):1181-93. 
14 Voigt-Radloff S, Hüll M. Daily functioning in dementia: Pharmacological and non-pharmacological inter-
ventions demonstrate small effects on heterogeneous scales – a synopsis of four health technology 
assessments of the German Institute for Quality and Efficiency in Health Care regarding the end-
point activities of daily living. Psychiatr Prax. Accepted. German. 
15 National Collaborating Centre for Mental Health (commissioned by the Social Care Institute for Excel-
lence and the National Institute for Health and Clinical Excellence). Dementia. A NICE-SCIE Guide-
line on supporting people with dementia and their carers in health and social care. National clinical 
practice guideline, number 42. London, The British Psychological Society and Gaskell 2007 
16 German Society for Psychiatry, Psychotherapy and Neurology and German Society for Neurology. Con-
sented Guideline "Dementia" [Internet]. 2009. [cited 2010 Oct 26]. Available from: 
http://media.dgppn.de/mediadb/media/dgppn/pdf/leitlinien/s3-leitlinie-demenz-lf.pdf  
17 Work Group on Alzheimer’s Disease and other dementias. Practice Guideline for the Treatment of Pa-
tients With Alzheimer’s Disease and Other Dementias [Internet]. 2007. [cited 2011 Aug 9]. Available 
from: http://www.psychiatryonline.com/pracGuide/PracticePDFs/AlzPG101007.pdf 
18 Steultjens EM, Dekker J, Bouter LM, Leemrijse CJ, van den Ende CH. Evidence of the efficacy of occu-
pational therapy in different conditions: an overview of systematic reviews. Clin Rehabil. 2005 
May;19(3):247-54. 
19 Voigt-Radloff S. Occupational therapy in dementia. In: Haberstroh J, Pantel J (Ed). Psychosocial treat-
ment in dementia. AKA Verlag Heidelberg: 2011. German 
 8
20 World Health Organization: International Classification of Functioning, Disability and Health (ICF) [Inter-
net]. Geneva: 2001. [cited 2011 Aug 9]. Available from: http://www3.who.int/icf/icftem 
21 Giovannetti T, Bettcher BM, Libon DJ, Brennan L, Sestito N, Kessler RK: Environmental adaptations 
improve everyday action performance in Alzheimer's disease: empirical support from performance-
based assessment. Neuropsychology 2007, 21(4):448-57.  
22 Gitlin LN, Hauck WW, Dennis MP, Winter L: Maintenance of effects of the home environmental skill-
building program for family caregivers and individuals with Alzheimer's disease and related disor-
ders. J Gerontol A Biol Sci Med Sci 2005, 60:368-74. 
23 Mittelman MS, Haley WE, Clay OJ, Roth DL: Improving caregiver well-being delays nursing home 
placement of patients with Alzheimer disease. Neurology 2006, 67(9):1592-9. 
24 Spijker A, Vernooij-Dassen M, Vasse E, Adang E, Wollersheim H, Grol R, Verhey F: Effectiveness of 
nonpharmacological interventions in delaying the institutionalization of patients with dementia: a 
meta-analysis. J Am Geriatr Soc 2008, 56(6):1116-28. 
25 Gitlin LN, Winter L, Burke J, Chernett N, Dennis MP, Hauck WW: Tailored activities to manage neuro-
psychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot 
study. Am J Geriatr Psychiatry 2008, 16(3):229-39. 
26 Parker D, Mills S Abbey J.Effectiveness of interventions that assist caregivers to support people with 
dementia living in the community: a systematic review. Int J Evid Based Healthc 2008; 6: 137–172 
27 Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW. A randomized, controlled trial of a home envi-
ronmental intervention: effect on efficacy and upset in caregivers and on daily function of persons 
with dementia. Gerontologist. 2001 Feb;41(1):4-14. 
28 Gitlin LN, Hauck WW, Dennis MP, Winter L. Maintenance of effects of the home environmental skill-
building program for family caregivers and individuals with Alzheimer's disease and related disor-
ders. J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):368-74. 
29 Graff MJL, Vernooij-Dassen MJFJ, Hoefnagels WHL, Dekker J, Witte de LP: Occupational therapy at 
home for older individuals with mild to moderate cognitive impairments and their primary caregivers: 
a pilot study. Occup Ther J Res 2003, 23:155-63. 
30 Graff MJ, Vernooij-Dassen MJ, Thijssen M, Dekker J, Hoefnagels WH, Rikkert MG: Community based 
occupational therapy for patients with dementia and their care givers: randomised controlled trial. 
BMJ 2006, 333(7580):1196. 
31 Graff MJ, Vernooij-Dassen MJ, Thijssen M, Dekker J, Hoefnagels WH, Olderikkert MG. Effects of com-
munity occupational therapy on quality of life, mood, and health status in dementia patients and 
their caregivers: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2007;62(9):1002-9. 
32 Graff MJ, Adang EM, Vernooij-Dassen MJ, Dekker J, Jönsson L, Thijssen M, Hoefnagels WH, Rikkert 
MG. Community occupational therapy for older patients with dementia and their care givers: cost ef-
fectiveness study. BMJ. 2008;336(7636):134-8. 
33 Graff MJL, Melick van MBM: The development, testing and implementation of an occupational therapy 
guideline. The guideline for the OT diagnosis and treatment of older persons with cognitive impair-
ments. Ned Tijdschr Ergother 2000, 28:169-74. In Dutch 
34 Graff MJL, Vernooij-Dassen MJ, Zajec J, Olde Rikkert MGM, Hoefnagels WHL, Dekker J: How can oc-
cupational therapy improve the daily performance and communication of an older patient with de-
mentia and his primary caregiver? A case study. Dementia 2006, 5:503-32. 
35 Graff MJL, Melick M van, Thijssen M, Verstraten P, Zajec J. Ergotherapie aan huis bij ouderen met de-
mentie en hun mantelzorgers. EDOMAH programma [Community occupational therapy for older 
people with dementia and their caregivers. COTiD programme] (Bohn Stafleu & van Loghum, June 
2010) [In Dutch] 
36 Waldemar G, Phung KT, Burns A, Georges J, Hansen FR, Iliffe S, Marking C, Rikkert MO, Selmes J, 
Stoppe G, Sartorius N. Access to diagnostic evaluation and treatment for dementia in Europe. Int J 
Geriatr Psychiatry. 2007 Jan;22(1):47-54. 
37 De Lepeleire J, Wind AW, Iliffe S, Moniz-Cook ED, Wilcock J, Gonzalez VM, Derksen E, Gianelli MV, 
Vernooij-Dassen M; Interdem Group. The primary care diagnosis of dementia in Europe: an analy-
sis using multidisciplinary, multinational expert groups. Aging Ment Health. 2008 Sep;12(5):568-76. 
38 Vernooij-Dassen MJ, Moniz-Cook ED, Woods RT, De Lepeleire J, Leuschner A, Zanetti O, de Rotrou J, 
Kenny G, Franco M, Peters V, Iliffe S. Factors affecting timely recognition and diagnosis of demen-
tia across Europe: from awareness to stigma. Int J Geriatr Psychiatry. 2005 Apr;20(4):377-86. 
39 Hausner L, Frölich L, Gardette V, Reynish E, Ousset PJ, Andrieu S, Vellas B,On Behalf Of The Ictus-
Eadc Study Group. Regional variation on the presentation of Alzheimer's disease patients in mem-
ory clinics within Europe: data from the ICTUS study. J Alzheimers Dis. 2010 Jan;21(1):155-65. 
40 Brodaty H, Mittelman M, Gibson L, Seeher K, Burns A. The effects of counseling spouse caregivers of 
people with Alzheimer disease taking donepezil and of country of residence on rates of admission 
to nursing homes and mortality. Am J Geriatr Psychiatry. 2009 Sep;17(9):734-43. 
41 Burns A, Mittelman M, Cole C, Morris J, Winter J, Page S, Brodaty H. Transcultural influences in demen-
tia care: observations from a psychosocial intervention study. Dement Geriatr Cogn Disord. 
2010;30(5):417-23. 
42 Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D; CON-
SORT group; Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic 
trials: an extension of the CONSORT statement. BMJ. 2008 Nov 11;337:a2390. 
43 Harrison MB, Légaré F, Graham ID, Fervers B. Adapting clinical practice guidelines to local context and 
assessing barriers to their use. CMAJ. 2010 Feb 9;182(2):E78-84. 
 9
2 
 
 
 
 
 
 
 
 
A multi-centre RCT on community 
occupational therapy in Alzheimer’s 
disease: Ten sessions are not better 
than one consultation 
 
 
Sebastian Voigt-Radloff, Maud Graff, Rainer Leonhart, Katrin Schornstein, 
Frank Jessen, Jens Bohlken, Brigitte Metz, Andreas Fellgiebel, Richard Do-
del, Gerhard Eschweiler, Myrra Vernooij-Dassen, Marcel Olde Rikkert, Mi-
chael Hüll 
 
 10
Abstract 
 
Objective: To compare the benefits and harms of a Dutch 10-session Commu-
nity Occupational Therapy programme for patients with Alzheimer’s disease 
with the impact of a one session consultation at home in German routine health 
care. 
 
Design: A seven-centre, parallel group, active controlled randomised controlled 
trial. Patients and carer were not masked. Assessors were fully blind for treat-
ment allocation for one of two primary-outcome measures. 
 
Setting: Patients' homes. 
 
Participants: Patients with mild to moderate Alzheimer's disease (Mini-Mental 
State Examination 14-24), living in the community with primary carer available 
and without severe depression or behavioural symptoms, were eligible. 
 
Interventions: Experimental 10 home visits within 5 weeks by an occupational 
therapist, educating patients in the performance of simplified daily activities and 
in the use of aids to compensate for cognitive decline; and educating carers in 
coping with behaviour of the patient and in giving supervision to the patient.  
Control one home visit including individual counselling of patient and carer and 
explanation of a leaflet on coping with dementia in daily life. 
 
Outcome measures: The primary outcome was the patient’s daily functioning 
measured with the Interview of Deterioration in Daily activities in Dementia and 
the Perceive, Recall, Plan and Perform System of Task Analysis. Assessments 
were at baseline, 6, 16, and 26 weeks, with a postal assessment at 52 weeks. 
 
Results: 141 patients were 1:1 randomised to the experimental (N=71) and 
control group (N=70). Data for 54 and 50 participants were analysed. Patients' 
daily functioning did not differ significantly between experimental and control 
group at week 6, 16, 26 or 52 and remained stable over 26 weeks in both 
groups. No adverse events were associated with the interventions. 
 
Conclusions: In German health care, a Dutch 10-session community occupa-
tional therapy was not better than a one-session consultation for the daily func-
tioning of patients with Alzheimer’s disease. Further research on the transfer of 
complex psychosocial interventions is needed. 
 
International Clinical Trials Registry Platform, DRKS00000053. Funded by the 
German Federal Ministry of Health. 
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Introduction 
 
Alzheimer’s disease causes high health care costs and burdens patients and 
carers with severe problems in activities of daily living (ADL).1 2 Consequently, 
the improvement or the preservation of ADL is evaluated as a patient-related 
outcome in clinical trials related to dementia.3 ADL, burden of care, ability to 
stay in the community and quality of life issues are probably much more rele-
vant to patients and carers than the deceleration of cognitive decline, another 
patient-related outcome.4 A synopsis of four systematic reviews analysing 73 
RCTs on the efficacy of pharmacological and psychosocial interventions regard-
ing everyday functioning in dementia concluded that positive effects of drugs on 
ADL are small (pooled effect sizes < 0.28) and heterogeneous regarding safety. 
In contrast to the well documented results for pharmacological interventions, 
evidence for psychosocial interventions on ADL is lacking.5 However, a recent 
Dutch mono-centre RCT demonstrated significant positive effects of occupa-
tional therapy on ADL (effect sizes of 2.4, p<0.0001).6 Therefore, the purpose of 
our multi-centre RCT was to transfer the Dutch community occupational therapy 
programme in a broader context of German routine healthcare and to evaluate 
its effectiveness and safety in comparison with an active-control-group interven-
tion.  
Occupational therapy specialises in supporting independence in ADL and is 
recommended in several guidelines for dementia management.7-9 Occupational 
therapy uses a combined approach including activity simplification, environ-
mental modification, adaptive aids, problem-solving strategies, skill training and 
carer training.7 10 11 According to the bio-psycho-social health model of the 
WHO, the negative impact of cognitive deficits on activities can be diminished 
by improving the patient's physical and social environment and by tailoring the 
intervention to the patient's capability.12-15 
Until July 2011, there was no systematic review on community occupational 
therapy for people with Alzheimer’s disease, but two research groups had con-
ducted RCTs in this subject. In the USA study, occupational therapy demon-
strated beneficial effects on patients’ challenging behaviours but not on ADL. 
No information on adverse events were given.14 16-18 In the Netherlands, occu-
pational therapy, tailored to the needs of patients and carers, showed benefits 
in the patient’s ADL, mood, health status and quality of life and in the carer’s 
sense of competence, mood, quality of life and costs of informal care. No ad-
verse events were reported in either intervention or control group.6 19 20 
In the current randomised trial, we tested the hypothesis that the Dutch 10-
session Community Occupational Therapy in Dementia Programme (COTiD) 
would significantly improve the daily functioning of people with mild or moderate 
dementia, more so than a one-session Community Occupational Therapy Con-
sultation (COTC). Secondary research questions were whether these interven-
tions would show any difference in their effect on patient’s and primary carer’s 
quality of life and mood; on the carer’s sense of competence in the interaction 
with the patient; and on long-term nursing home placements. 
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Methods 
 
Design 
In order to evaluate the superiority of COTiD, we used a seven-centre single-
blind, active-controlled design with a 1:1 randomisation for two parallel groups. 
There was no modification in design or eligibility criteria from the study protocol 
available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761388/. The study 
was registered at the German register of clinical trials, which is connected to the 
International Clinical Trials Registry Platform (http://apps.who.int/trialsearch/ => 
DRKS00000053). The Medical Ethics Committee of the University Hospital 
Freiburg gave ethical approval (no. 110/08). 
 
Participants and Setting 
Patients were eligible to participate in the study if they had mild to moderate 
dementia (Mini-Mental State Examination (MMSE) 14-24) and were diagnosed 
as having Alzheimer's disease or mixed type dementia, according to the Tenth 
Revision of International Classification of Disieases criteria, by physicians with 
more than 5 years of experience in dementia diagnosis. Participants had to live 
in the community either together with their primary carer or with involvement of 
a carer providing care at least twice a week. Patients with a score above 12 on 
the 30-items Geriatric Depression Scale or a major need of physical nursing 
care of more than 120 min per day (level 2 or higher according to the German 
Long-Term Care Insurance Act) were excluded. Unstable medical conditions or 
severe behavioural disturbances, which did not allow participation in the study 
as judged by the study physicians, were criteria for exclusion as well as for dis-
continuation. Long-term nursing-home placements of the patients during the 
treatment phase or death of patient or primary carer were criteria for discon-
tinuation. The patient gave written informed consent and the carer consented by 
written format to join and support the treatment procedures.  
Patients were recruited from five outpatient memory centres at university hospi-
tals (in Bonn, Freiburg, Mainz, Marburg and Tübingen); one municipal hospital 
in Karlsruhe specialising in geriatric medicine; and one neurological private 
practice in Berlin specialising in neuropsychiatry and collaborating with an oc-
cupational therapy private practice. The seven participating centres are located 
throughout Germany in urban regions with catchment areas of about 70,000 to 
700,000 inhabitants. They had all provided outpatient dementia care for 3-15 
years. Their standard service comprised diagnostic work-up for dementia and 
related diagnoses as well as recommendation of risk reduction, dementia medi-
cation and non-pharmacological treatments. Principal investigators of the cen-
tres were psychiatrists, neurologists or geriatricians with 6-13 years of experi-
ence in dementia care.  
 
Interventions 
The experimental intervention (COTiD) was designed to improve the patient’s 
and the primary carer’s daily functioning, and was based on an evidence-based 
treatment manual.6, 19-23 COTiD consisted of 10 occupational therapy sessions 
of 1 hour’s duration held over five weeks at each patient’s home. In the diagnos-
tic phase, comprising three of four sessions, the occupational therapist explored 
(1) the patient’s preferences and history of daily activities; (2) their ability to per-
form activities and to use compensatory strategies within the familiar environ-
ment; (3) the possibilities of modifying the patient’s home; (4) the carer’s activity 
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preferences, problems in care giving, coping strategies and abilities to super-
vise; and (5) the interaction between carer and patient. In a shared decision-
making process during the goal setting session, the patient and the carer se-
lected the one or two most meaningful activities out of a list of their preferences 
for daily activities to work on in occupational therapy. During the treatment 
phase of five to six sessions, the occupational therapist defined, together with 
the patient and the carer, more effective compensatory and environmental 
strategies to adapt both the environment and the selected activities to the pa-
tient's habits and cognitive abilities. Patient and carer were taught how to use 
these suggested adaptations within strategies, activities and the environment in 
order to improve their performance of daily activities. In addition, the carer re-
ceived practical and emotional support and was coached in effective supervi-
sion, problem solving and coping strategies by means of cognitive-behavioural 
interventions. Detailed description of the experimental intervention has been 
published elsewhere.23  
For the German RCT, MG taught the content of the translated treatment manual 
to 14 study-participant occupational therapists in 16 hours of seminars using 
presentation, videos and role play with feedback and group discussion. After the 
seminar and before the study started, they needed to complete a full treatment 
series for at least one pilot dyad of patient and carer. In the study phase, the 
interventionists spent about 20 hours per patient for a full treatment series in-
cluding 10 treatment sessions, travel, reports and a multidisciplinary briefing. In 
Germany, a series of 10-30 sessions is within the normal range of time that oc-
cupational therapists use for the treatment of older outpatients diagnosed with 
other diseases, such as stroke or rheumatoid arthritis.  
The control group received 1 h of COTC at the patient’s home conducted by the 
same study interventionists. Based on material of the German Alzheimer Soci-
ety, two occupational therapists with more than 5 years of experience in demen-
tia care had prepared a leaflet of 10 pages.24 25 The semistructured consultation 
was an explanation of 30 min of this leaflet and a talk of 30 min on individual 
problems that arose from the patient’s and carer's needs. This included encour-
agement to stay active in everyday life, to maintain social contacts and to use 
dementia services in the region for which local addresses were listed in the leaf-
let. Occupational therapists were taught the control intervention within a 4 h 
seminar. Consultations of 30 min up to 1 h duration about such issues are 
common in German dementia care. A detailed description of the control inter-
vention as well as means of quality assurance in experimental and control inter-
vention has been published elsewhere.26 
 
Outcome measures 
The primary endpoint was the patients’ change of daily functioning from base-
line to follow-up time points at week 6, 16 and 26 measured with the perform-
ance scale of the Interview for Deterioration in Daily Living Activities in Demen-
tia (IDDD).27 This scale records carer rating of the patient's need for assistance 
in the performance of (1) washing oneself, (2) making tea or coffee, (3) dress-
ing, (4) combing one's hair and brushing one's teeth, (5) eating, (6) using the 
toilet, (7) shopping, (8) using the telephone, (9) preparing a meal, (10) cleaning 
the house or doing minor repair work and (11) handling finances. Each item is 
rated never=0, seldom=1, sometimes=2, often=3 or always=4. The sum of 
scores ranged from 0 to 44. Higher scores indicated higher need for assistance. 
Since carer rating could not be ‘masked’, daily functioning was additionally 
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evaluated by external raters fully ‘blind’ to the group assignment. They rated 
video tapes of a challenging daily living task and used the Perceive, Recall, 
Plan and Perform System of Task Analysis (PRPP).28 For the PRPP, raters had 
to define single steps of the performed activity, and they identified any activity 
step in which errors of accuracy, omission, repetition or timing occurred. The 
number of activity steps rated as incorrectly performed was divided by the total 
number of activity steps, resulting in an independence score indicated in a per-
centage (100%=all steps are error-free).  
 
Table 1: Measurements of secondary endpoints26 
Endpoint Measurement 
Patient’s initiative in daily activities Interview for Deterioration in Daily Living Activities in Dementia (IDDD), 
initiative scale 
Patient’s mood  Cornell Scale for Depression in Dementia (CSDD) 
Carer’s mood Center for Epidemiologic Depression Scale (CES-D) 
Dementia Quality of Life Instrument (DQoL), overall item 
SF-12 physical 
Patient and carer’s 
quality of life 
SF-12 mental 
Carer’s interaction with patient Sense of Competence Questionnaire (SCQ) 
Care by primary carer Resource Utilization in Dementia (RUD), hours per day 
Nursing home placement RUD, nights in nursing home (except respite care)  
Number of adverse events  Harms 
RUD, nights in hospital 
 
Secondary endpoints included mood, quality of life, resource utilisation and 
possible harms (table 1). Assessors ‘blind’ for the group assignment, completed 
measurements at the patient’s home at baseline, week 6, 16 and 26 and ar-
ranged a postal survey of carer questionnaires at week 52. The assessors had 
a minimum of one year's professional experience with older or cognitively im-
paired people. They attended an introductory seminar of 8 h. The complete as-
sessment was applied during a 2 h visit at each patient’s home including (1) 
handing out and explaining the questionnaires to the carer; (2) interviewing the 
patient (Dementia Quality of Life Instrument and Short-Form 12 Health Survey 
Questionnaire) in a separate room; (3) videotaping the patient; and (4) receiving 
back the carer questionnaires, checking it and clarifying answers if necessary. 
Seminar descriptions and means of quality management for assessment as well 
as detailed scheme and psychometric properties of all measurement instru-
ments have been reported recently.26 
All measurement instruments are validated and used in dementia research.29 30 
For the present study, we translated the IDDD into German according to high 
methodological standards with two independent forward and backward transla-
tions, analysis of discrepancies and final agreement by discussion with all trans-
lators. There was no need to translate the PRPP because, because it was es-
tablished in The Netherlands and applied by Dutch raters. There was one pro-
tocol amendment before recruitment started. The Assessment of Motor and 
Process Skills was replaced by the PRPP, because the Assessment of Motor 
and Process Skills was not available in the German language within the 
planned schedule. 
Indicators of harm were defined as patient or carer death, number of patients 
with admission to hospital and number of nights in hospital. These indicators 
were recorded in interviews with the carer at intervals of 5-7 weeks over 52 
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weeks. Study sites had to report severe adverse events to the study centre im-
mediately when each occurred. We did not assume a direct association be-
tween the defined harms and either the experimental or the control intervention. 
However, increased daily activities in the interventions group might have re-
sulted in a higher risk of falls or accidents and thus may indirectly have led to 
more nights in hospital or, in the worst case, to death. 
 
Sample size calculation 
A sample size of 42 participants per group was calculated to be necessary to 
detect an effect size of f=0.10 on the IDDD performance scale in an analysis of 
variance of two groups and four time points, using a two-sided 5% significance 
level, a power of 80%, and a correlation of 0.7 between the measurement time 
points.31 According to the Dutch original RCT, we expected a dropout rate of 
10% at week 16, which was extrapolated to 40% at week 52. A 9-month inclu-
sion period was anticipated as necessary in order to recruit the 140 patients. 
Our assumed effect size of f=0.10 is based on a group-by-time interaction and 
compatible with Cohen’s d=0.20, which corresponds to a small effect size, and 
any d over 0.8 is large. Although the Dutch original RCT found effect sizes of 
d=2.4 in the IDDD performance scale at week 12, for this study the power was 
calculated much more conservatively. This was because we (1) introduced an 
active control group, (2) investigated the programme effects under varying care 
conditions in seven centres with interventionists who were introduced in this 
new treatment and were not as experienced as the Dutch study therapists and 
(3) prolonged the follow-up period. Interim analyses were not planned. 
 
Randomisation and masking 
The random allocation sequence was computer-generated with blocking by cen-
tre and groups of two persons, without stratification and in a ratio of 1:1 by a 
statistician from a distant site. After enrolment, study site physicians requested 
randomisation via email. The statistician emailed the individual allocation to 
COTiD or COTC exclusively to the site interventionist and stored the allocation 
list at his distant site which was not available to any study site staff. The inter-
ventionist scheduled treatment sessions, faxed records to the distant coordinat-
ing study centre and kept all documents strictly separated from any other site 
staff. This was in order to avoid contamination. Since the numbers of home vis-
its differed in the experimental and control groups, masking of patients and car-
ers was not possible. However, study information did not include any preference 
for a special treatment ‘arm’. Patients and carers were asked to give no infor-
mation about their treatment package to assessors or study physicians. All 
study personnel were ‘blind’ for group assignment, except the interventionists. 
Agreement between the assessors’ estimation of group assignment and the 
actual group assignment was 61%, and thus slightly over the expected 50% of 
agreement by chance. The procedure of external video rating ensured the full 
'blinding' of the external raters for the PRPP primary outcome measure. Inde-
pendent research assistants cleaned the videotapes of any hint of group as-
signment before they were rated by two Dutch raters not involved in the trial 
treatment. In order to establish the inter-rater reliability, we tested 10 double 
ratings of the same video by the two raters and found an intraclass correlation 
coefficient of 0.9. Data analysts were not ‘blind’ for the group assignment. How-
ever, measurement time points and outcomes had been published before data 
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Assessed for eligibility (n=228)
Excluded (n=87) 
Ineligible (n=47) 
Eligible but not recruited (n=40) 
Allocated to occupational therapy (n=71) 
61 Received complete allocated intervention  
6 Allocated intervention was incomplete 
4 Did not receive allocated intervention (1 patient 
admitted to hospital; 2 withdrew without reason; 
1 withdrew as carer felt stressed) 
Follow-up at 6 weeks (n=66) 
2 Lost for follow up 
3 Withdrew (1 no reason; 1 patient not con-
vinced; 1 carer felt stressed) 
Allocation 
and 
Intervention
Randomisation and baseline assessment (n = 141)
Follow-up at 16 weeks (n=59) 
2 Lost for follow up 
5 Withdrew (1 no reason; 1 patient not con-
vinced; 3 carer felt stressed) 
Follow-up at 26 weeks (n=55) 
2 Lost for follow up 
1 Withdrew (patient ill) 
1 Carer died 
Follow-up at 52 weeks (n=54) 
1 Lost for follow up 
Allocated to control (n=70) 
66 Received complete allocated intervention  
4 Did not receive allocated intervention (with-
drew: 1 no reason; 2 carer ill; 1 carer felt 
stressed) 
Follow-up at 6 weeks (n=63) 
2 Lost for follow up 
5 Withdrew (1 no reason; 1 patient ill; 1 carer felt 
stressed; 2 carer ill) 
Follow-up at 16 weeks (n=55) 
2 Lost for follow up 
5 Withdrew (1 patient ill; 2 carer not convinced; 
2 carer felt stressed) 
1 Patient admitted to nursing home 
Follow-up at 26 weeks (n=50) 
3 Lost for follow up 
1 Withdrew (1 patient ill) 
1 Patient died 
Follow-up at 52 weeks (n=50) 
Follow up
Analysis
were available for analysis26 and any decision to remove patients from the 
analyses is reported in the present publication.  
 
Figure 1: Flow of participants through the trial 
 
 
Statistical methods  
Data were entered via special MS Access entry masks automatically controlling 
for data plausibility. In addition, sections of entered data were checked for typ-
ing errors by hand, in order to ensure an error rate lower than 0.2%. The pri-
mary intention-to-treat analysis included all allocated participants with valid data 
whether they did or did not receive the complete intervention. For the IDDD and 
the PRPP measurements of the primary outcome, we performed a multivariate 
analysis of variance (MANOVA) with repeated measures with two groups and 
four measurement time points at baseline, week 6, 16 and 26. A univariate 
ANOVA with five measurement time points (+ postal assessment in week 52) 
was carried out for the secondary outcomes and the IDDD. We did not adjust 
for baseline values, because we found no marked group differences. In order to 
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deal with missing data occurring not in the primary but in the secondary out-
comes, we performed secondary intention-to-treat analyses with multiple data 
imputation using the Full Information Maximum Likelihood (FIML) method.32 We 
imputed data for all secondary outcome measurements and all time points using 
SPSS (V.19). All statistical tests were two-sided on an α level of 0.05. Subgroup 
analyses were not planned. 
 
 
Results 
 
Recruitment and participant flow 
We prolonged the planned recruitment period from August 2008 to April 2009 
by one additional month, up to May 2009. This was in order to recruit the in-
tended sample size. The 52-week follow-up was closed in May 2010.  
One hundred and forty-one participants were recruited (Berlin: 19; Bonn: 21; 
Freiburg: 26; Karlsruhe: 15; Mainz: 24; Marburg: 21; Tübingen: 15). The flow 
chart (Figure 1) shows that attrition following randomisation did not lead to sig-
nificant group differences. 
 
Baseline Characteristics 
Randomisation did avoid imbalances in baseline characteristics (Table 2) and 
pre-treatment assessment data (Table 3) except in one item. Participants in the 
control group had more moderate to severe limitations in their financial situation 
(14% v 2%; p=0.027). Because the financial situation is not known as predictive 
factor for functional decline, we did not adjust for this imbalance.33  
 
Table 2: Demographic and clinical characteristics 
COTiD Control  
analysed 
(n=54) 
dropouts 
(n=17) 
total 
(n=71) 
analysed 
(n=50) 
dropouts 
(n=20) 
total 
(n=70) 
Age, years (SD) 78.0 (7.1) 77.2 (8.5) 77.8 (7.4) 78.7 (6.0) 78.3 (7.1) 78.5 (6.3) 
Sex, female 29 (54 %) 12 (71 %) 41 (58 %) 30 (60 %) 10 (50 %) 40 (57 %) 
MMSE (SD) 20.4 (3.1) 19.0 (3.3) 20.2 (3.2) 20.7 (2.7) 20.3 (2.9) 20.7 (2.7) 
GDS (SD) 6.9 (3.0) 5.6 (2.9) 6.5 (3.0) 5.2 (2.8) 6.1 (2.6) 5.5 (2.8) 
Education       
no school graduation 2 (4 %) 1 (6 %) 3 (4 %) 1 (2 %) 0 (0 %) 1 (1 %) 
middle school graduation (9 or 10 years) 41 (76 %) 13 (76 %) 54 (76 %) 37 (74 %) 15 (75 %) 52 (74 %) 
high school graduation (12 or 13 years) 11 (20 %) 3 (18 %) 14 (20 %) 12 (24 %) 5 (25 %) 17 (24 %) 
Financial situation as perceived by the carer       
no limitation 40 (74 %) 14 (82 %) 54 (76%) 38 (76 %) 13 (65 %) 51 (73 %) 
minor limitation 12 (22 %) 1 (6 %) 13 (18 %) 3 (6 %) 3 (15 %) 6 (9 %) 
moderate or severe limitation 1 (2 %) 2 (12 %) 3 (4 %) 7 (14 %) 4 (20 %) 11 (16 %) 
no data 1 (2 %) 0 (0.0 %) 1 (1 %) 2 (4 %) 0 (0 %) 2 (3 %) 
Primary carer       
Age, years (SD) 65.4 (16.3) 63.1 (14.0) 64.9 (15.7) 65.9 (13.0) 61.4 (17.4) 64.5 (14.4) 
Sex, female 38 (70 %) 9 (53 %) 47 (66 %) 35 (70 %) 18 (90 %) 53 (76 %) 
Spouse 32 (59 %) 8 (47 %) 40 (56 %) 31 (62 %) 9 (45 %) 40 (57 %) 
Daughter or son (in law) 20 (37 %) 7 (41 %) 27 (38 %) 16 (32 %) 9 (45 %) 25 (36 %) 
Others 2 (4 %) 2 (12 %) 4 (6%) 3 (6 %) 2 (10 %) 5 (7 %) 
Living together (%) 41 (76 %) 11 (65 %) 52 (73%) 33 (66 %) 14 (70 %) 47 (67 %) 
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Intervention delivery 
61 of 71 (86%) allocated patient-carer dyads received complete sessions in the 
COTiD group, 66 of 70 (94%) in the control group. In each group, 4 pairs were 
lost before intervention. Six patient-carer dyads in the COTiD had less than 10 
sessions. Interventionists rated the delivery of 20 pre-defined treatment sub-
processes, ranging from interviewing patient and carer to training of simplified 
activities or supporting the carer in supervision. They scored treatment delivery 
as 78% in the COTiD group and 80% in the control group. Interventionists rated 
the patient’s adherence in 67 cases of the COTiD group, from 15 as hindering 
the delivery of treatment; 26 as neutral and 26 as facilitating. Rating criteria 
were the patient’s cooperation during interview, goal setting and training; the 
daily changing mental capacity; collaboration with the carer; and the acceptance 
of innovations. Ratings of carers’ adherence were 5 hindering; 15 neutral; and 
47 facilitating. The carer adherence was assessed with regard to the coopera-
tion during scheduling, interview, goal setting and training to supervise; the en-
couragement of the patient; the acceptance of support service; and the imple-
mentation of innovations. The adherence of the participants in the control group 
could not be rated, because interventionists had no further contact after the 
consultation.  
 
Outcomes  
The MANOVA in 104 completers (COTiD: n=54; control: n=50) revealed no sig-
nificant group time interaction effect in the primary outcome measurements of 
patients’ daily functioning (Figures 2 and 3). Using the arcsine transform [34] for 
the PRPR percentage did not change results (original: p = 0.243; arcsine-
transform: p = 0.216). An additional mixed models analysis of all randomised 
patients (N=141) as recommended by Coley and colleagues [35] did reveal no 
significant interactions for the IDDD (p=0.340) and the PRPP (p=0.785). Tables 
3 and 4 show mean, standard deviation and group difference including 95%-
confidence intervals of an ANOVA for all outcomes. Patients’ daily functioning 
did not significantly change over 26 weeks in either the experimental and con-
trol group. In the postal 52 weeks follow up, the patients’ need for assistance 
increased in both groups, and accordingly the carer’s hours of care for basic 
ADL were higher. Two patients of the COTiD group were placed to nursing 
homes 33 and 44 weeks after baseline and one patient of the control group af-
ter 33 weeks. 
To address the problem of missing data in single measurement instruments, we 
performed a multiple data imputation. We calculated a MANOVA over four 
measurement time points for all primary and secondary outcomes for all 104 
completers. Ten different data imputations did not reveal any significant time 
group interaction effects.  
We also tested for study sites differences at baseline and found no significant 
differences in a MANOVA with the factors study sites and intervention groups 
(F(66, 432)=1.079, p=0.323). Furthermore, no study site effect was found in the 
primary outcome analysing IDDD and PRPP data of baseline, week 6, 16 and 
26 (IDDD: F(6, 90)=0.724, p=0.631; PRPP: F(6, 90)=1.758, p=0.117). 
 
Harms 
There were no differences between intervention and control group, neither in 
the number of adverse events nor in their severity. The study site physicians 
judged all adverse events as unrelated to trial treatment or assessment con-
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tacts. In the total sample of all randomised participants (n=141), two deaths of 
patients (both in the control group) and one death of carer (in the COTiD group) 
were reported. In the COTiD group, 14 patients were admitted to hospital for an 
average of 15 nights; and 10 patients in the control group, for an average of 18 
nights. There was no difference between the two groups in average number of 
nights admitted to hospital (F(1, 97)=2.785, p=0.1). All events were unrelated to 
the occupational therapy sessions. 
 
Figure 2: ADL task performance of Alzheimer patients following intense occupational therapy compared 
with a single session control intervention; means and 95%-confidence intervals of the PRPP independ-
ence scale (N=104 completers; range: 100=no errors to 0=all errors)  
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Figure 3: Need for assistance in ADL of Alzheimer patients following intense occupational therapy com-
pared with a single session control intervention; means and 95%-confidence intervals of the IDDD per-
formance scale (N=104 completers; range: 0=never needed assistance to 44=always needed assistance) 
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Discussion 
 
In the results of this study, a ten-session community occupational therapy in dementia 
programme (COTiD) was found to be no more beneficial than a one-session consulta-
tion concerning short- and middle-term effects on patients’ daily functioning. In both 
groups, the need for assistance in basic and instrumental activities of daily living and the 
performance of a self-chosen daily living task remained stable up to six months after 
baseline. No significant group differences could be found on secondary outcomes, which 
were quality of life and mood of patient and primary carer; patient’s initiative in daily ac-
tivities; carer’s sense of competence in interaction with the patient; carer’s hours of daily 
care; and the patient’s nursing home placement. There were no adverse events associ-
ated with experimental or control intervention. 
Limitations  
Despite an elaborate study design, there are some limitations in this study. We analysed 
only 104 completer dyads from 141 recruited pairs (74 %). However, (1) baseline data of 
completers and non-completers did not show imbalance; (2) dyads were maintained, 
whose data were valid, and for whom treatment was intended but not received in the 
complete ITT-analysis; (3) an additional mixed model analysis of all randomised patients 
did also not reveal significant differences; and (4) the analysis of the reduced patient 
sample with valid data did not show even a tendency towards significant group differ-
ences. Thus the hypothesis of group differences must be rejected, because the analysis 
of completers usually favours results in the direction of group differences. 
A second shortcoming was that following the common introductory seminar the start of 
the study differed amongst the sites owing to different time lines in administrative mat-
ters and approval of the local ethic commissions. Therefore, a common repetition semi-
nar for the interventionists could not be arranged after the pilot training. This may have 
led to some heterogeneity in the intervention, especially because in Germany eleven 
newly introduced interventionists performed the treatment compared to two experienced 
experts in the original Dutch trial. We addressed this problem with feedback on videos of 
treatment sessions the interventionists sent in. Furthermore, we arranged telephone su-
pervision on demand.  
We consider the contamination of the control intervention with knowledge from the ex-
perimental intervention to be low, because any specific intervention such as activity se-
lection, simplification or training was precluded by the limited time to carry out the con-
trol intervention.  
Comparison 
The Dutch RCT on the COTiD with waiting-control-group design showed large effect 
sizes in the IDDD performance scale at six and twelve weeks after baseline (d=2.3 and 
2.4, respectively).[6] The Dutch and the German sample did not differ remarkably in 
cognition at baseline (MMSE: 19 v 20), but did differ in the need for assistance (IDDD 
performance: 24 v 15). The German patients showed a low need for assistance at the 
beginning of the study. This was comparable to the IDDD values of the Dutch patients at 
the end of the treatment. This may have caused a floor effect on the IDDD. Another 
mono-centre RCT in the USA compared community occupational therapy and a less 
intensive telephone consultation in patients with probable dementia (MMSE: 13).[36] 
The authors found a small effect size in daily functioning (d=0.21). The initial need for 
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assistance in both studies was higher than in the German sample. A systematic review 
of community programmes in dementia [37] reported one study on exercise and behav-
ioural management with beneficial effects on daily functioning of patients with moderate 
dementia (MMSE: 17); one trial on occupational therapy with heterogeneous effects; 
and two studies on occupational therapy and music therapy with no significant effects. A 
current German health technology assessment on non-drug therapies in Alzheimer’s 
disease did not identify further community occupational therapy trials [38]. The compari-
son of community intervention trials reveals that study samples with a lower MMSE and 
a higher need for assistance benefit more than those with initial higher cognitive and 
daily functioning. Similarly, a standardized synopsis of ADL outcomes in pharmacologi-
cal dementia trials indicated that samples with an MMSE between 17 and 10 benefit 
most in ADL while samples with higher MMSE scores showed less effects.[39] However, 
different baseline scores of cognitive and daily functioning alone cannot explain the ma-
jor difference between the findings in this German study and the positive results of the 
Dutch RCT. Detailed process evaluation and exploratory analyses of the study data 
might show whether variations in study site context and treatment performance influ-
enced the intervention’s effectiveness. 
Clinical and research implications 
Published evidence for the effectiveness of community occupational therapy in dementia 
is heterogeneous as indicated by a Dutch trial with large positive effects on daily func-
tioning; a few USA trials with no or small positive effects on ADL and this German study 
showing that ten sessions were not better than one consultation. A preventative one-
session consultation might be hypothesised as beneficial for people with mild dementia 
and an improved 10-session programme more specifically adapted to the German 
health care system as beneficial for dementia patients with moderate need for assis-
tance in ADL, as was shown in the Dutch study in which most people with dementia had 
moderate to high need for assistance at baseline.  
Although we had expected smaller effect sizes than in the Dutch original trial owing to 
changed study design with (1) the introduction of an active control group, (2) a variance 
in treatment performance in several centres, (3) a prolonged follow up time and (4) rig-
orous reduction of the analysed sample to participants with valid data, it remains surpris-
ing that significant group difference could not be found in any of the primary or secon-
dary outcomes.  
This study has shown that careful cross-national comparisons are greatly needed, espe-
cially in complex interventions, before they can be considered evidence based and im-
plemented effectively in other health care systems. Therefore, further analyses must 
investigate the role of interventionists’ expertise and treatment performance, and the 
role of participants’ needs and utilisation of health care resources, before conclusions on 
international implementation of this intense occupational therapy intervention can be 
drawn.  
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Abstract 
 
Background: The positive effects of the Dutch Community Occupational Therapy in 
Dementia programme on patients’ daily functioning were not found in a multicentre RCT 
in Germany.  
 
Objectives: To evaluate possible effect modification on the primary outcome within the 
German RCT with regard to (1) participant characteristics, (2) treatment performance, 
and (3) healthcare service utilisation; and (4) to compare the design and primary out-
come between the German and the original Dutch study. 
 
Methods: (1) The impact of participant baseline data on the primary outcome were ana-
lysed in exploratory ANCOVA and regression analyses. (2) Interventionists completed 
questionnaires on context and performance problems. The main problems were identi-
fied by a qualitative content analysis and focus group discussion. Associations of the 
primary outcome with scores of participant adherence and treatment performance were 
evaluated by regression analysis. (3) Utilisation rates of healthcare services were con-
trolled for significant group differences. (4) Differences of the Dutch and German study 
design were identified and primary outcome was contrasted at the item level. 
 
Results: (1) Participant characteristics could not explain more than 5 % of outcome 
variance. (2) The treatment performance of some active intervention components was 
poor but not significantly associated with the primary outcome. (3) There were no signifi-
cant group differences in the utilisation of health care resources. (4) In contrast to the 
Dutch waiting-control group, the active intervention in the German control group may 
have reduced group differences in the current RCT. The German patients demonstrated 
higher independence at baseline and less improvement in instrumental activities of daily 
living.  
 
Conclusion: The differences in outcome may be explained by a more active control 
treatment, partially poor experimental treatment and less room for improvement in the 
German sample. Future cross-national transfers should be prepared by pilot studies as-
sessing the applicability of the intervention and patient needs specific to the target coun-
try.  
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Introduction 
 
New guidance from the British Medical Research Council states that developing and 
evaluating complex interventions can be a lengthy process. All steps should sufficiently 
be addressed. These steps include (1) the development of the intervention, (2) a pilot 
study on feasibility, (3) a randomised controlled trial (RCT) on effectiveness and (4) an 
evaluation of implementation in health care practice.1 Cross-national transfer of complex 
intervention can speed up the uptake of innovative and effective programmes from one 
country to another. Time and resources might be saved when an intervention pro-
gramme which was already developed, piloted and evaluated on effectiveness in one 
country can directly be proven regarding effectiveness in the healthcare context of an-
other country. We followed this approach by transferring the Dutch evidence-based 
Community Occupational Therapy in Dementia Programme (COTiD)2 to the German 
health care system and testing its effectiveness in a seven-centre RCT.3 However, the 
highly positive effects of the Dutch COTiD on patients’ daily functioning could not be 
found. Process evaluation is recommended as highly valuable in RCTs to provide insight 
into unexpected intervention failure.4 Differences in participants as well as aspects of 
treatment performance and contextual factors should be assessed with regard to their 
associations with the primary outcome.5-7 Based on these recommendations, our proc-
ess evaluation investigated four research questions. We evaluated both possible bias 
within the German study (question 1-3) and differences between the Dutch and German 
RCT (question 4).  
1. Did specific patient or carer characteristics influence a patient’s outcome after the 
intervention? 
2. What problems and variations in experimental treatment performance could be iden-
tified in the study context and did they influence the daily functioning of patients? 
3. What differences in the utilisation of further healthcare resources during the treat-
ment period could be identified and did they influence the daily functioning of pa-
tients? 
4. What differences between the Dutch and the German study could be identified in 
terms of design and primary outcome? 
 
 
Methods 
 
1. Specific participant characteristics of the German sample 
The outcome of interest was daily functioning indicated by two measurement instru-
ments, the Interview for Deterioration in Daily Living Activities in Dementia (IDDD) and 
the Perceive, Recall, Plan and Perform System of Task Analysis (PRPP). The IDDD per-
formance scale records the patients' need for assistance in 11 basic and instrumental 
activities of daily living.8 In the PRPP, the number of errors occurring during the per-
formance of a self-chosen daily living task is measured.9 An ANCOVA was used to in-
vestigate the mean changes from baseline in the IDDD and PRPP between the COTiD 
and control group controlling for (1) the patient’s age, gender, education and financial 
limitation; and the daily activities, mood and cognition at baseline; and (2) the carer’s 
gender, education, relationship to the patient; and the sense of competence and mood 
at baseline. Data were collected with standardised measurement instruments as de-
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scribed in the study protocol and were in line with a recent health-technology assess-
ment of risk or protective factors for Alzheimer’s disease.10, 11 Percentage variance ex-
plained in mean changes from baseline in the IDDD and PRPP was assessed using 
multiple regression.  
 
 
Table 1: Statements by interventionists stating main performance problems within the therapeutic subprocesses 
Setting therapy goals “Priorisation by the patient was difficult, because he was very uncritical”. 
“The carer wants immediately to talk about problem solving. I again and again had to suggest the pro-
cedure [of systematic shared goal setting]”. 
Educating patient in 
new skills 
“Patient needs much guidance. Concentration and endurance [are] very limited. Assistance for simple 
tasks [is needed]”. 
“Activities agreed on could not be carried out twice owing to apathy and depressive mood”. 
“In addition, patient had dyspraxia, which made training difficult”. 
“[There was a] lack of training owing to the negative attitude of the carer”. 
“It is difficult for the patient to accept the disease. Therefore a high degree of convincing is needed in 
each session”. 
Adapting physical or 
social environment 
“The carer is the house owner and refuses any adaptation”. 
“[Adapting physical environment] does not succeed because the carer is ostensibly open for interven-
tion, but in reflective talks reluctant and negative”.  
“An adaptation [of the physical environment] seems not reasonable to the patient, although [it is] nec-
essary”. 
“[Adapting physical environment] is possible only step by step, because the patient reacts on it with 
reluctance”. 
“The patient lives rather reclusively, wishes no changes [in the social environment]”. 
“The patient is very anxious and avoiding [change]“. 
„The son strongly adheres to old patterns of interaction“. 
“The family dynamic is very fixed. Both daughters seem to have difficulty in just letting the mother [pa-
tient] simply do … Changes take place, but very slowly. [It is] questionable, whether there will be work 
on the goals after the intervention is finished”. 
“In the community, there is no day care and no care centre for people with dementia”.  
Training of carer’s 
competence 
“The son [is] often not or only temporary present at the sessions”. 
“[The carer is] many a time overstrained and tries to give away [the responsibility] to the therapist” 
“It is difficult for the carer to get used to something new. He quickly falls back into old patterns [of be-
haviour] without being aware of it”. 
“[The carer] seems to be very overstrained and burdened by the disease. He needs additional profes-
sional support e.g. from a psychologist“.  
“The carer has need for support, but refuses any offer of support for himself.”  
“The carer mostly sees only his own problems. He can not or only very rarely empathises with the 
patient. Offers of support are refused”. 
„There are difficulties in the interaction between the family and the patient. The patient plays off the 
caring family members against each other”. 
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2. COTiD performance in the German experimental group 
Interventionists completed semi-structured questionnaires during and after the treatment 
period. (Questionnaires are available in German from the corresponding author.) During 
the treatment phase, they reported reasons for a problematic performance of 20 sub-
processes for each experimental case. The sub-processes were defined according to 
the study protocol (table 1 and 4). After the treatment period, interventionists described 
and rated their professional experience in the field and their valuation of introduction, 
pilot phase and supervision, as well as inhibiting and facilitating processes at the study 
site. A qualitative content analysis with inductive category development was used to 
identify the main performance problems from the comments given in the question-
naires.12-16 A focus-group discussion served as a member check, in order to achieve 
consensus among the interventionists about the main performance problems.17-21 Fur-
thermore, the interventionists dichotomously scored the 20 treatment sub-processes as 
performed either with or without problems. These scores were used to operationalise the 
quality of performance for each case. The best quality was indicated by 100% when all 
sub-processes were performed without any problems.  
The interventionists also rated patient adherence regarding the cooperation during the 
interview, the goal setting and the training; as well as regarding the patient’s daily 
changing mental capacity, their collaboration with the carer and regarding the accep-
tance of innovations. Additionally, the carer adherence was assessed with regard to 
their cooperation during the scheduling, the interview, the goal setting and the training of 
supervision, as well as with regard to their encouragement of the patient, the accep-
tance of support service and the implementation of innovations. Interventionists rated 
these indicators for adherence on a five-point-Likert scale ranging from ‘very facilitating 
for the treatment performance’ (=1) to ‘very hindering for the treatment performance’ 
(=5).  
Correlations between the mean changes from baseline in the IDDD and PRPP and 
scores of the performance quality and the participant adherence were calculated (Pear-
son coefficient). An exploratory regression analysis was deemed to be appropriate for 
smaller samples, and this was to evaluate whether such scores could explain variance 
in the mean changes from baseline in the IDDD and PRPP.22 
 
3. Utilisation of healthcare resources in the German study 
The Resource Utilisation in Dementia23 was applied to collect patient data during the 
treatment period on (1) the number of consultations with general practitioners, neurolo-
gists/psychiatrists and other medical specialists; (2) the time for individual therapy such 
as physio-, speech- or psychotherapy; (3) the time for group therapy such as cognitive 
stimulation or exercise groups; (4) times of receiving nursing or domestic home care; (5) 
the number of technical aids implemented within the patient’s home; and (6) increasing, 
decreasing, constant or no intake of acetyl cholinesterase inhibitors. Furthermore co-
morbidity indicating a possible need for further healthcare services was rated using the 
Cumulative Illness Rating Scale.24 These data were tested for the significance of group 
differences between the experimental and the control arm (nonparametric two-tailed 
Mann-Whitney-U test owing to the negative skewness of the data distribution). 
 
4. Comparison between the Dutch and the German study 
Regarding the patient characteristics and change from baseline to follow-up on the pri-
mary outcome, we compared the single IDDD items of the Dutch and the German sam-
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ple within the identical measurement period of five weeks from baseline to the first follow 
up measurement at week 6. This was in order to assess whether both samples had the 
same room for improvement in items which indicate the need for assistance in daily ac-
tivities. Furthermore, we compared the expertise of the Dutch and German intervention-
ists in terms of pre-experience with the experimental intervention and intensity of treat-
ment delivery (patients per interventionist) and the study designs regarding the control-
group intervention. 2 3 
 
 
Results 
 
1. Specific participant characteristics of the German sample 
The mean changes to baseline in the IDDD and the PRPP were neither associated with 
carers’ socio-demographic or baseline assessment data nor with patients’ socio-
demographic data or baseline mini mental state (table 2). We found a minor correlation 
of mean changes to baseline in the IDDD with patients’ mood at baseline (Cornell Scale 
for Depression in Dementia, CSDD25; r=0.21; p=0.044).  
 
 
Table 2: Pearson correlation coefficient of specific participant characteristics and mean changes to baseline in the IDDD and the 
PRPP (German completers of the Community Occupational Therapy in Dementia Programme and control group) 
 
N 
Perceive, Recall, Plan and 
Perform System of Task 
Analysis9 change to baseline 
Interview for Deterioration in 
Daily Living Activities in De-
mentia8 change to baseline 
Patient    
Age 104 -0.02 0.11 
Gender 104 -0.16 -0.11 
Education 104 -0.13 -0.02 
Financial limitation 93 0.07 0.14 
Mood, Cornell Scale for Depression in De-
mentia25 baseline 95 0.16 0.21* 
Cognition, MMSE baseline 104 0.02 0.10 
Carer    
Gender 104 0.08 -0.11 
Education 104 -0.12 0.11 
Relationship to patient 104 0.15 0.09 
Sense of competence, Sense of Compe-
tence Questionnaire (SCQ)26 baseline 103 -0.06 -0.02 
Mood, Center for Epidemiologic Depression 
Scale 27 baseline 103 0.09 0.09 
*p<0.05 (two-tailed)    
  
 
A stepwise regression analysis using patient and carer characteristics as listed in table 2 
could not explain more than 5 % of variance in change over time of patient’s daily func-
tioning. Adjusted ANCOVA using patient’s baseline values of the CSDD, the PRPP and 
the IDDD as independent variables did not yield any significant group differences in the 
dependent variables, which were the mean changes to baseline in the IDDD and the 
PRPP (results not shown). This indicated that after correction for baseline scores of 
mood and daily functioning, there were still no significant differences on the primary out-
come in the German sample with moderate to good daily functioning at baseline. 
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2. COTiD performance in the German experimental group 
Eleven interventionists from seven study sites delivered the COTiD to 54 patients. The 
interventionists’ characteristics (table 3) varied in previous years in dementia care from 1 
year part time to 11 years full time, in perceived facilitators from quite facilitating to 
slightly hindering and in the quality of treatment performance from 52 to 90% of optimal 
performance. The data did not provide stable patterns in the sense that many previous 
years in dementia care and high values of perceived facilitators did lead to a high quality 
of treatment performance or vice versa.  
 
Table 3: Characteristics of the 11 interventionists who delivered Community Occupational Therapy in Dementia Programme 
(COTiD) to 54 patients with Alzheimers (German completers of the COTiD group) 
Basic data  Perceived facilitators§  Treatment performance 
Age Gender Years in occu-pational therapy 
Years in 
dementia care 
Pre-existing 
knowledge 
Study  
preparation 
Site 
support Total Cases 
Quality 
(%)& 
27 Male 3 3 2.2 2.0 1.1 1.8 3 86  
31 Female 8 5 1.6 2.0 1.2 1.6 3 89  
45 Female 9 7 1.8 2.5 2.2 2.2 5 94  
44 Female 7 1* 3.2 1.7 1.8 2.2 2 64  
40 Male 13 13* 3.8 3.0 2.4 3.1 10 81  
34 Female 5 3 3.8 2.5 2.8 3.0 10 90  
54 Male 11 11 2.0 3.5 2.7 2.7 4 73  
36 Female 11 9 2.3 2.7 2.6 2.5 1 52  
39 Female 18 12* 2.4 2.5 2.9 2.6 2 74  
40 Female 6 3* 2.4 3.3 2.9 2.9 2 59  
32 Female 9 9* 4.2 3.3 3.4 3.4 12 84  
*part-time; §scored by interventionists with 1=very facilitating, 2=facilitating, 3=neutral, 4=hindering, 5=very hindering; &100%=all 
treatment sub-processes were performed without problems 
 
The quality of the subprocess performance (table 4) did also vary from receiving full 
medical information in 52 of 54 cases (96%) to successfully adapting physical environ-
ment in 24 cases (44 %). Subprocesses relating to therapeutic active agents as identi-
fied by Graff et al.15 were performed with no problems at only a low frequency with 76 % 
for setting therapy goals, 46 % for training of patient’s skills, 44 and 46 % for adapting 
physical and social environment and 59 and 54 % for training of carer’s competence in 
instruction and problem-solving. In the questionnaires, the interventionists gave com-
ments representing the main performance problems in these subprocesses (table 4). 
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Table 4: Quality of sub-processes of Community Occupational Therapy in Dementia Programme (COTiD) performance in 54 Alz-
heimer’s disease patients (German completers of the COTiD group) 
Performance* 
Sub-processes Good (%) Poor Main problems  
01 Receiving medical information  52 (96) 2 Received wrong phone number or no detailed medical information 
02 Making appointments with participants 49 (91) 5 Participants had other appointments 
03 Travelling to participants 46 (85) 8 Long travel to patient’s home (some > 40 km) 
04 Meeting the participants 50 (93) 4 Participants forgot to cancel the date and were late or not at home  
05 Contacting and providing confidence 50 (93) 4 Patient was sceptic or abrasive 
06 Informing about the procedure 50 (93) 4 Patient could not understand procedure, misunderstood procedure 
as test for nursing home placement 
07 Observing the timeframe 42 (78) 12 Participants (mainly carer) had a great need to tell and talk 
08 Explaining clearly, responding to ques-
tions  
50 (93) 4 Patient could not understand explanation owing to communication 
deficits or mood swings 
09 Mastering conflicts and problematic 
situations 
39 (72) 15 Patient had severe mood swings or additional cognitive deficits or 
was not aware of deficits; carer was overstrained, abrasive or 
placed sole responsibility on therapist; family conflicts existed for a 
long time 
10 Interviewing patient with OPHI 38 (70) 16 Patient was not or hardly able to tell, had anomia or severe deficits 
in biographic memory or was disoriented 
11 Observing patient activity with Voli-
tional Questionnaire, if OPHI not done 
5 (71*) 2 Patient not motivated to demonstrate activities; *Volitional Ques-
tionnaire not necessary in 47 cases, because OPHI was done 
12 Interviewing carer with  
Ethnographic Interview 
47 (87) 7 Carer had only little understanding of dementia or felt very bur-
dened 
13 Observing activities  
of patient and carer 
43 (80) 11 Patient did activity incompletely, was very passive or was fraught 
when being observed; carer was demanding or inpatient 
14 Setting therapy goals with patient and 
carer 
41 (76) 13 Participants negated need for change or could not specify goals 
15 Defining occupational therapy prob-
lems 
43 (80) 11 Patient had no activity limitations; participants could not under-
stand the relevance of problems; problems were very complex or 
became clearer only later during intervention or were not related to 
dementia but depression or physical limitations. 
16 Educating patient in new skills and 
compensation capability 
25 (46) 29 Patient was not or hardly motivated in training, additional symp-
toms such as dyspraxia, depression, apathy, attention deficit 
disorder hampered the training; carer or family were not supportive 
17 Adapting physical environment 24 (44) 30 Participants refused or hesitantly accepted necessary adaptations 
18 Adapting social environment  25 (46) 29 Participants were reluctant to change social environment; informal 
social support or care services were lacking  
19 Training of carer’s competence in 
instruction and interaction 
32 (59) 22 Carer could not change behaviour as being very burdened or 
inpatient or bound in firm habits; was not willing to take responsi-
bility or was missing sessions 
20 Training of carer’s competence in 
problem solving 
29 (54) 25 Carer was not willing to undertake the responsibility of problem 
solving or not able to do so owing to high burden; carer would 
have needed more time or further support to undertake the re-
sponsibility for independent problem solving. 
* Number of cases, in which the performance of this sub-process was rated as unproblematic (=good) or problematic (=poor). OPHI, 
Occupational Performance History Interview 
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Association between COTiD performance and primary outcome  
We found no significant associations between the scores of COTiD performance and 
changes to baseline in the IDDD and in the PRPP (detailed data not shown). Since there 
was a poor performance of those subprocesses which were related to active therapeutic 
agents (nos 14 to 20; table 4), we further analysed the association between the per-
formance score of these subprocesses and the changes to baseline in the IDDD and in 
the PRPP. A minimal correlation was found, r=0.268 (p=0.05) only with the PRPP. No 
association was found between carer adherence and the changes to baseline in the 
IDDD and in the PRPP. The score of patient adherence and the change to baseline in 
the PRPP demonstrated a moderate correlation of r=-0.317 (p=0.02). The subsequent 
regression analysis revealed that patient adherence could explain 10 % of the variance 
(p=0.02) in the PRPP change to baseline. The IDDD change to baseline could not be 
explained by patient or carer adherence, or by the quality of treatment performance. 
 
Table 5: Utilisation of further healthcare resources of patients with Alzheimers during the intervention period of intense occupa-
tional therapy compared with a single session control intervention (German completers of the Community Occupational Therapy in 
Dementia Programme (COTiD) and control group) 
COTiD (n=54)  Control (n=50) 
Healthcare resources Mean (SD) Range Skewness Mean (SD) Range  Skewness 
Medical consultations per week       
General practitioner 0.28 (0.40) 0 - 2.33 3.211 0.18 (0.17) 0 - 0.67 0.828 
Neurologist or psychiatrist 0.04 (0.09) 0 - 0.33 2.092 0.03 (0.09) 0 - 0.50 3.508 
Other medical expert 0.14 (0.26) 0 - 1.33 2.778 0.15 (0.24) 0 - 1.00 1.825 
Hours for therapy per week       
Individual therapy 0.14 (0.32) 0 - 1.00 2.029 0.11 (0.29) 0 - 1.00 2.597 
Group therapy 1.05 (2.92) 0 - 14.00 3.064 0.88 (3.32) 0 - 16.00 4.163 
Hours for nursing or domestic home care per week 1.33 (3.23) 0 - 15.08 3.074 1.87 (5.32) 0 - 25.54 3.173 
Number of technical aids provided at home 0.15 (0.49) 0 - 3.00 4.306 0.06 (0.24) 0 - 3.00 3.821 
Comorbidity (Cumulative Illness Rating Scale24) 3.15 (3.20) 0 - 13 1.101 2.42 (2.60) 0 - 11 1.374 
No of patients with acetylcholinesterase-inhibitor medication 
De-novo treatment or increased dose 4 (7%)   3 (6%)   
Decreased dose or medication ceased 2 (4%)   1 (2%)   
Constant level 34 (63%)   26 (52%)   
No AchE-inhibitors 14 (26%)   20 (40%)   
 
3. Utilisation of healthcare resources in the German study 
The COTiD group had a somewhat higher co-morbidity index, slightly more visits to 
general practitioners and somewhat less hours for nursing or domestic home care. 
Negative skewness in the data distribution indicated that many participants had a low 
utilisation rate and only a few participants had a high intensity of resource utilisation (ta-
ble 5). However, we found no significant differences on group level within the German 
trial in any resource utilisation or co-morbidity. The subgroups of patients with decreas-
ing or increasing acetylcholinesterase inhibitor medication were too small to detect any 
significant group differences. However, the daily functioning in the COTiD group was not 
better than in the control group, although more COTiD patients received acetylcholi-
nesterase inhibitors at a constant level (COTiD, 63 % vs control, 52 %).  
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4. Comparison between the Dutch and the German study 
 
Differences in the room for improvement in the IDDD 
Table 6 shows that the COTiD group in the Dutch sample did notably improve in 
household instrumental activities of daily living (IADL), only marginally in basic activi-
ties of daily living and not at all in handling finances. Graff et al.2 defined 20% im-
provement as being clinically relevant, which is indicated by a pre-post-treatment dif-
ference of 0.8 on item level. The household IADL items demonstrated such differ-
ences and, therefore, a high responsiveness to the COTiD programme. Thus, the 
household IADL items can be presumed to be a therapeutic window basically provid-
ing room for improvement given a sufficient need for assistance in these items at 
baseline. Comparing the Dutch and the German COTiD groups, the baseline values 
in these IADL items differed considerably more than in the other IDDD items. 
The German patients showed much less need for assistance in this area. The limited 
room for improvement in the German sample is obvious when regarding the baseline 
differences between the Dutch and the German sample. Analysis of a German sub-
sample matched to the Dutch sample with comparable need for assistance in these 
household IADL-items at baseline was not possible owing to the low number of Ger-
man patients with such baseline values.  
 
Differences in design 
The German trial design included a comprehensive consultation as active control in-
tervention which approximately represents the non-pharmacological standard care in 
Germany. This was in order to evaluate possible benefits of COTiD additional to 
standard care. Compared to the waiting-control-group design of the Dutch original 
trial, the German active control intervention may have reduced the group differences 
in daily functioning after the treatment. Compared with the Dutch therapists, the inter-
ventionists in Germany had less experience with COTiD before their study involve-
ment (NL: 240 h vs GER: 0 h), less seminar and training time in the study preparation 
phase (80 vs 40 h) and fewer COTiD patients per interventionist during the treatment 
period (34 vs 5). 
 
 
Discussion 
 
The process evaluation of our multi-centre RCT on community occupational therapy 
in Alzheimer’s disease revealed that the characteristics of the German participants at 
baseline did not mediate patients’ daily functioning after treatment as indicated by the 
mean change to baseline in the IDDD and PRPP. Some sub-processes, which 
deemed to be active components of the applied complex psycho-social experimental 
intervention, were performed poorly. However, variances in the performance were not 
associated with patients’ mean change to baseline in the IDDD and PRPP. The utili-
sation of further health care resources was equal in the experimental and control 
groups. Based on exploratory analyses of process data, we can reject the hypothesis 
that group differences in participant characteristics, variances in the treatment per-
formance or in the utilisation of further health care resources had a confounding in-
fluence on the primary outcome within the German study sample. The analyses were 
limited by the restriction of range in the IDDD baseline data within the German sam-
ple. However, the variance of the IDDD baseline data in the German sample was 
higher than in the Dutch sample (German sample: experimental group, mean 15.4 
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(SD 9.9); control group, 14.1 (10.1); Dutch sample: experimental group 23.5 (7.9); 
control group, 24.5 (8.7)). 
Using the same eligibility criteria, the German sample showed much less room for 
improvement in daily functioning than the Dutch sample. In Germany, patients’ daily 
functioning at baseline was much better. Most German patients still performed better 
at the end of the study irrespective of group assignment than the successfully treated 
Dutch group, in which patients had lower baseline scores and improved significantly. 
This underlines the importance to pay attention to the needs of the patients and care 
givers specific to the target country. 
In the German study, the self reported performance of active intervention compo-
nents was not associated with the primary outcome. The small sample size and the 
method of self-rating are limitations for detecting such associations. Although an ex-
ploratory regression analysis is vulnerable to missinterpretation22, we also per-
formed this type of analysis, in order to detect any signs of an influence of treatment 
performance on the primary outcome. However, we found only minor rates of correla-
tion and explanation, which makes any meaningful association between variances in 
the treatment performance and the primary outcome unlikely. Self-rating can be a 
feasible approach for adherence evaluation in dementia research28, in order to deal 
with limited resources.29 However, interventionists tend to overestimate their own 
performance.30 Although the interventionists were explicitly asked to be critical when 
judging their own performance, for further studies it is recommended that there be an 
additional external monitoring of treatment performance. This may reduce possible 
bias introduced by over-estimation or over-criticism in self-rating. Furthermore, it 
might help to find appropriate onsite coaching strategies. These strategies should 
aim at high quality treatment performance even though the complexity of psycho-
social interventions induces variances – especially in multi-centre RCTs.  
Data on the association of treatment performance and primary patient outcomes, al-
though encouraged,5, 31 are scarce in RCTs studying complex interventions. Teri et 
al.25 implemented an external video rating of therapists’ adherence to protocol but 
found no associations between this rating and any outcome variable. Similar studies 
in the field29, 30 did not operationalise the impact of treatment performance on the 
primary outcome as the British Medical Research Council had strongly recom-
mended.1 Within the original Dutch RCT, the large number of patients treated by two 
highly motivated interventionists from the same study site suggests an excellent qual-
ity of treatment performance.2 However, its association with the patients’ outcome 
was not quantified. The experiences with the subsequent Dutch implementation of 
the guidelines revealed that novices had difficulties in adapting to this highly complex 
intervention in a concrete treatment setting. Prior to cross-national implementation of 
complex interventions, a successful national transfer from a single-centre setting with 
highly motivated specialists to a multi-centre routine setting with therapists varying in 
competence and motivation seems to be appropriate.  
 
Conclusion 
Our process evaluation revealed that the participants in the study may have had in-
sufficient need for the applied treatment and that active components of the complex 
psycho-social intervention were poorly performed. Also, an interaction can be con-
sidered in the sense that little need for assistance can make a less intensive, one-
session treatment appropriate, as applied to the control group. These recent experi-
ences suggest that cross-national transfers are best prepared by a pilot study in the 
target country exploring specific patient needs, the feasibility of inclusion criteria, the 
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usability of measurement instruments and the applicability of the complex interven-
tion by therapists in routine care settings.  
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Abstract 
 
Background: The purpose of the study was to translate the Interview of Deteriora-
tion in Daily Living Activities in Dementia (IDDD) into German and to evaluate the 
construct and concurrent validity in people with mild to moderate dementia. 
 
Methods: IDDD data of two pooled samples (n=301) were analysed regarding ceiling 
and bottom effects, internal consistency, factor reliability and correlations with corre-
sponding scales on cognition and activities of daily living. 
 
Results: We found minimal bottom (< 5 %) and ceiling (≤ 2 %) effects, good internal 
consistency (Cronbachs α > 0.7) and moderate to good factor reliability (0.66 to 
0.87). Low correlations with cognition (Pearson coefficient: < 0.17) confirmed the dif-
ferences between cognitive testing and activities of daily living (ADL). Minor correla-
tions with other ADL scores (r < 0.2) indicated that different scores cover a different 
range of ADLs. The original two factor model could not be confirmed. A suggested 
four factor model distinguishing initiative and performance of basic and instrumental 
ADL demonstrated better indices of fit and higher correlations with corresponding 
scales. 
 
Conclusion: A four factor model of the IDDD can be used in dementia research for 
assessing initiative in and performance of basic and household activities of daily liv-
ing. The findings suggest that ADL scales correlate only poorly and that further de-
velopment of the IDDD is needed to cover a broader range of ADLs. 
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Introduction 
 
The independent performance of daily activities is one of the most relevant outcomes 
for people with dementia. Family carers claimed that dementia research should focus 
more on the outcome of daily functioning than on cognition (Georges et al., 2008). 
International guidelines demand the assessment of activities of daily living (ADL) in 
dementia research (European Medicines Agency, 2008; National Collaborating Cen-
tre for Mental Health, 2007; Institute for Quality and Efficiency in Health Care, 2009; 
Work Group on Alzheimer’s Disease and other dementias, 2007). A recent synopsis 
of four Health Technology Assessments reporting the results of 27 pharmacological 
and 13 psychosocial intervention RCTs regarding the endpoint daily functioning re-
vealed that very heterogeneous ADL scales were used (Voigt-Radloff and Hüll, 
2011). For harmonisation, the INTER-DEM group sought for a consensus on appro-
priate outcome measures (Moniz-Cook et al., 2008). Although the group stated that 
an adequate dementia-specific measure for the endpoint ADL is not available at pre-
sent, they considered the Interview of Deterioration in Daily Living Activities in De-
mentia (IDDD; Teunisse and Derix, 1997) among several other scales to be appro-
priate when metric properties will be confirmed through further validation studies.  
 
The IDDD consists of two scales recording the carers’ rating of patients’ initiative and 
performance of daily living activities. The Initiative Scale measures the initiative for 
(1) washing oneself, (2) making tea or coffee, (3) dressing, (4) combing one’s hair 
and brushing one’s teeth, (5) shopping, (6) using the phone, (7) preparing a meal, (8) 
cleaning the house or doing minor repair work and (9) handling finances. The Per-
formance Scale records the need of assistance in the performance of the same nine 
activities plus eating and using the toilet. Both domains of the IDDD are constructed 
as five-point-Likert-scales with the ratings never=0, seldom=1, sometimes=2, of-
ten=3, always=4. Scores of the Initiative Scale range from 0 to 36. Higher scores in-
dicate higher initiative. The Performance Score ranges from 0 to 44. Higher scores 
indicate higher need for assistance. In a sample of 451 persons, the IDDD demon-
strated great internal consistency (Cronbach’s alpha=0.99), reproducibility (intraclass 
correlation coefficient ICC=0.94) and significant differences between groups of pa-
tients with mild cognitive impairment and patients with dementia (Böhm et al., 1998). 
In a sample of 25 primary and secondary carer pairs, the IDDD interrater reliability 
was high (ICC: 0.85 for the Initiative Scale and 0.74 for the Performance Scale; Te-
unisse and Derix, 1997). In an RCT on psychosocial intervention, the Performance 
Scale demonstrated high responsiveness by indicating clinically relevant improve-
ment in 78% of cases in the intervention group and 12 % of cases in the control 
group 6 weeks after baseline and 82 % and 10 % respective after 12 weeks (Graff et 
al., 2006).  
 
While these results provide evidence for the reproducibility, interrater reliability and 
responsiveness of the IDDD, studies on its construct and concurrent validity are 
missing. Therefore the purpose of the present validation study was to translate the 
IDDD into German and to evaluate the internal consistency, construct validity and 
correlation with corresponding scales of this translated version in two samples of 
people with mild to moderate dementia. 
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Methods 
 
Design 
Two independent RCTs funded by the Federal German Health Ministry set the frame 
for data collection. These multi-site randomised trials evaluated the effectiveness of 
community occupational therapy on daily functioning of people with mild to moderate 
dementia.  
The WHEDA trial from Freiburg included seven study sites and 141 participants. In-
clusion criteria were the diagnose Alzheimer’s disease or mixed type and a MMSE 
score between 14 and 24. Patient had to live in the community and a carer had to be 
available twice a week. Participants with major depression and severe behavioural 
disturbances were excluded.  
The ERGODEM trial from Dresden comprised three sites and 160 patients. The crite-
ria for the eligibility to participate in the study were the same as in the WHEDA trial 
with two exceptions. Patients with vascular dementia according to DSM-IV were also 
included and the range of the MMSE score was broader (12-26). 
 
Measurement Instruments 
Two assessment instruments on activities of daily living and two measurements on 
cognition were applied assuming a possible association with the IDDD. 
 
Table 1: Measurement scheme 
Variables Freiburg Dresden 
Demographics    
Age x x 
Gender x x 
Relation to carer x x 
Activities of Daily Living   
IDDD, carer-rated x x 
ADCS-ADL, carer-rated  x 
PRPP, performance test x  
Cognition   
MMSE, performance test x x 
ADAS-cog, performance test  x 
 
The WHEDA trial used the Perceive, Recall, Plan and Perform System of Task 
Analysis (PRPP) to evaluate a patient’s common daily activity (Chapparo and Ranka, 
2006). In this assessment, a trained rater defines single steps of a performed activity 
to be analysed and identifies any activity step in which errors of accuracy, omission, 
repetition or timing occur. The number of activity steps rated as incorrectly performed 
is divided by the total number of activity steps, resulting in an independence-score 
indicated in percent (100 % = all steps are error-free). Content validity was shown in 
a comparative analysis of the same activities of daily living of 25 healthy adults and 
20 persons with brain injury. Variations of performance but no errors occurred within 
the healthy sample. Clearly observable errors within the sample with brain injury 
could be catalogued in the four main categories accuracy, omission, repetition or tim-
ing. Interrater reliability of three raters in a sample of 15 adults with schizophrenia 
was moderate (ICC: 0.77; Chapparo and Ranka, 2006). Nott et al. (2008) found fair 
test-retest reliability and high internal consistency (ICC>0.8). 
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The informant-based Alzheimer’s Disease Cooperative Study Activities of Daily Living 
Inventory (ADCS-ADL) was applied in the ERGODEM trial. It assesses 17 instrumen-
tal and 6 basic ADL. The scoring categories differ between 0 to 3 and 0 to 5 depend-
ing on the item. The total score of the ADCS-ADL ranges from 0 (positive, highly in-
dependent) to 78 (negative, highly dependent). In a sample of community dwelling 
older people with mild to moderate Alzheimer’s Disease, each of the 27 items was 
tested for correlation with the MMSE (Spearman R: 0.28-0.70) and for test-retest-
reliability after 1 and 2 months (Kappa: 0.40-0.73; Galasko et al., 1997). 
The Mini Mental State Examination (MMSE) and the Alzheimer’s Disease Assess-
ment Scale cognitive (ADAS-cog) are established tests of cognitive performance 
(Demers et al., 2000). 
 
Procedures 
Our procedures followed the latest guideline on cross-cultural translation and valida-
tion (Sousa and Rojjanasrirat, 2010). We used Dutch as source and German as tar-
get language. English was the common language in all phases to explore the mean-
ing of terms in the source and target languages and to resolve inconsistencies by 
using descriptions of intended meanings. 
Forward translations: Two native German speakers, excellent in Dutch and fluent in 
English independently translated the instructions, items and response format. One of 
them is living in the Netherlands and working in Germany. The second translator is 
living in Germany, but studied psychology in the Netherlands for five years.  
Synthesis of forward translations: The project manager of the WHEDA-study com-
pared the forward-translated versions and achieved an agreement with the transla-
tors by discussing ambiguities and discrepancies in a synthesised version. 
Backward translations: Two native Dutch speakers, excellent in German and fluent in 
English, independently translated the preliminary German version back to Dutch. One 
translator published on language issues in qualitative research (Van Nes et al., 
2011). 
Synthesis of backward translations: The Dutch translators compared the two back-
ward-translated Dutch versions and transferred the Dutch discrepancies to the Ger-
man version and explained it with English comments using single Dutch words when 
necessary. The project manager moderated the discussion of all four translators 
about the synthesised version considering all highlighted ambiguities and discrepan-
cies of the forward and backward versions. Agreement on the final version was 
achieved by discussion.  
Pilot-testing: The assessors involved in the WHEDA trial attended a seminar on the 
IDDD application and applied it to carers of patients with mild to moderate dementia. 
The assessors listed aspects facilitating or hindering the IDDD application within a 
written cognitive debriefing on the response process (Frost et al., 2007; Cook and 
Beckman, 2006). The assessors involved in the ERGODEM trial attended a training 
comprising detailed instructions for the application of the instrument. 
Full psychometric testing: Patients of the participating centres with mild to moderate 
dementia were informed during a routine visit or via an invitation letter. The study 
physician informed both patient and carer and received written informed consent and 
full agreement with the contents and procedures of the study also from both patient 
and primary carer. The primary carer had to be a family member or friend living to-
gether with or providing informal care for the patient at least twice a week. Trained 
physicians, psychologists or study nurses collected data of the MMSE and ADAS-cog 
at the study site. The assessors handed over the IDDD and the socio-demographic 
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questionnaires to the primary carer, received it back and clarified questions and un-
clear answers with the carer within the same session. In the Dresden trial, the pri-
mary carers completed the ADCS-ADL contemporaneous with the other question-
naires. In the Freiburg trial, the assessors videotaped the patient’s performance of a 
selected activity of daily living, which was rated by external raters using the PRPP. 
The patient, the carer and the assessor jointly selected one out of 20 defined every-
day activities considering that the task must be meaningful for this patient and that he 
must not be able to demonstrate an effective and fully independent task perform-
ance, so that room for improvement of the performance is given. At the coordinating 
study centres, questionnaires were checked for completeness and plausibility, typed 
in, checked again for typing errors and analysed. 
 
Statistical analysis 
Descriptive statistics: IDDD scales were reported with means, standard deviation, 
and frequency of best and worst possible values (ceiling and bottom effects). 
Construct validity and internal consistency: We applied confirmatory factor analyses, 
in order to evaluate whether the scale structure of the IDDD can be replicated in 
other samples. Internal consistency was indicated by Cronbach's alpha. 
Concurrent validity: Pearson correlation coefficients were calculated for both IDDD 
scales and scores of the PRPP, ADCS-ADL, MMSE, and ADAS-cog. 
 
 
Results 
 
Translation  
There was a discussion on how to call the patient, when the relative is addressed in 
the questionnaire: your relative vs patient vs the ill person vs person with dementia. 
We decide for the ill person because this term is in German a single word and has 
the connotation of someone who is cared for, but not only medically. The use of the 
term your relative would have excluded non family carers. 
Two misinterpretations could be prevented due to the comparison of the forward and 
backward translations. (1) The item using the toilette without soiling was not meant 
as without soiling oneself, but without soiling the toilette. (2) The forward translation 
of the item doing tasks in and around the house such as cleaning, repairing some-
thing or gardening could be misleading, because the carer might associate also big-
ger tasks such as renovating and caring for the whole garden. To avoid such misin-
terpretation we agreed on the amendment doing minor tasks. 
 
Pilot-testing  
14 Assessors provided data of 21 IDDD questionnaires. All carers could complete the 
IDDD, except of one who felt that he did not know the patient well enough. No item 
response was missing in the provided 20 questionnaires. Of 400 possible response 
items, 7 (<2%) were answered with “do not know” and 28 (7%) with “activity was 
never done” indicating that the carers could rate most of the daily activities and that 
these activities were relevant to the patients. The assessors observed that motiva-
tion, sufficient cognitive ability and diligence of the carer facilitate the completion of 
the IDDD. Furthermore, the fact that the carer was asked to mark any unclearness or 
open question directly on the form was very supportive, as well as the assessor’s 
check of each response directly when he received back the questionnaire. We con-
cluded that a change in the wording was not necessary and that the data collection 
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will be optimised, when trained assessors ask the carer to note unclear points and 
directly check the responses for completeness and plausibility.  
  
Table 2: Baseline characteristics 
 Freiburg (FR) Dresden (DD) p Total sample 
N 141 160  301 
MMSE, mean (SD) 20.5 (2.9) 20.8 (3.9) 0.401 20.7 (3.5) 
Age, years (SD) 78.2 (6.9) 76.5 (7.3) 0.039 77.3 (7.2) 
Gender, female (%) 81(57.4%) 92 (57.9%) 0.942 173 (57.7%) 
Spouse as primary carer (%) 100 (62.9%) 80 (56.7 %) 0.277 180 (60.0 %) 
 
Descriptive results 
We pooled the data from both samples, Freiburg (N=141) and Dresden (N=160). 
Baseline characteristics were similar and differed only in age, which however was still 
in a typical range for people with mild to moderate dementia (table 2). Descriptive 
data indicate that on average patients only sometimes showed initiative to perform 
activities of daily living but seldom needed assistance (table 3). Minimal bottom ef-
fects were found in the performance scale (4.3 % with best scale values). 
 
Table 3: IDDD descriptive data (Freiburg and Dresden sample, N=301) 
 No. of Items Mean SD Median Bottom effects$ Ceiling effects$ 
IDDD performance (0-44)§ 11 16.8 10.9 16.1 13 (4.3%) 2 (0.7%) 
IDDD initiative (36-0)§ 9 17.5 9.0 17.1 3 (1.0%) 6 (2.0%) 
IDDD= Interview of Deterioration in Daily Living Activities in Dementia 
§ Range: positive to negative; $ No. of cases with worst/best scale values 
 
Construct validity  
The IDDD scales demonstrated good internal consistency with Cronbachs α=0.878 
for the performance scale and α=0.764 for the initiative scale (table 4). Only for the 
item handling finances, we found low corrected item-to-scale-correlations in both 
scales. However, the factor analysis of the IDDD model revealed a significant chi-
square (χ2 =1396, df=169, χ2/df=8.261, p<0.001) indicating a difference between 
empirical and estimated data and a bad fit for the model. Further indices (Kline 1998) 
confirmed an insufficient model fit (Root Mean Square Error of Approximation, 
RMSEA=0.156 [good fit: <0.08]; Tucker-Lewis Index, TLI=0.574; [good fit: >0.9] 
Comparative Fit Index, CFI=0.657 [good fit: >0.95]). The initiative scale showed low 
factor reliability (r=0.66, table 5). Especially items of instrumental activities of daily 
living (shopping, using telephone, preparing a meal, cleaning house or doing repair 
work and handling finances) demonstrated very low correlations (r<0.2, table 5). 
Considering this, we developed a four factor model based on the clinically relevant 
distinction between basic and instrumental activities of daily living. The new model 
demonstrated an acceptable fit according to the indices recommended by Kline 
(1998; χ2=431, df=160, χ2/df=2.696, p<0.01; RMSEA=0.075; TLI=0.911; CFI=0.925) 
and an excellent internal consistency with Cronbachs alpha as follows: 
α = 0.897 for IDDD performance of basic ADL (01 washing oneself, 03 dressing, 04 
combing hair and brushing teeth, 05 eating, 06 using the toilet) 
α = 0.838 for IDDD performance of instrumental ADL (02 making tea or coffee, 07 
shopping, 08 using the telephone, 09 preparing a meal, 10 cleaning house 
or doing repair work, 11 handling finances) 
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α = 0.967 for IDDD initiative for basic ADL (01 washing oneself, 03 dressing, 04 
combing hair and brushing teeth) 
α = 0.820 for IDDD initiative for instrumental ADL (02 making tea or coffee, 05 shop-
ping, 06 using the telephone, 07 preparing a meal, 08 cleaning house or 
doing repair work, 09 handling finances). 
 
Table 4: Interview of Deterioration in Daily Living Activities in Dementia - internal consistency 
Scale N Cronbachs 
alpha 
Items Mean 
item  
SD Corrected item-to-
scale-correlation 
Cronbachs alpha 
without item 
290 0.878 01 Washing oneself 0.96 1.38 0.678 0.862 
  02 Making tea or coffee 1.53 1.66 0.725 0.857 
  03 Dressing 1.16 1.41 0.709 0.860 
  04 Combing hair and brushing teeth 0.84 1.31 0.655 0.864 
  05 Eating 0.46 1.10 0.429 0.877 
  06 Using the toilet 0.68 1.18 0.585 0.868 
  07 Shopping 2.30 1.68 0.562 0.870 
  08 Using the telephone 1.63 1.53 0.636 0.864 
  09 Preparing a meal 2.17 1.75 0.592 0.868 
  10 Cleaning house or doing repair work 1.96 1.54 0.660 0.862 
Performance 
 
  11 Handling finances 3.02 1.48 0.273 0.887 
295 0.764 01 Washing oneself 1.91 1.78 0.482 0.736 
  02 Making tea or coffee 2.01 1.71 0.694 0.702 
  03 Dressing 1.81 1.86 0.360 0.757 
  04 Combing hair and brushing teeth 1.87 1.77 0.456 0.740 
  05 Shopping 2.08 1.64 0.510 0.732 
  06 Using the telephone 2.01 1.46 0.501 0.735 
  07 Preparing a meal 1.93 1.67 0.462 0.739 
  08 Cleaning house or doing repair work 1.82 1.52 0.611 0.719 
Initiative 
 
  09 Handling finances 2.04 1.75 0.023 0.804 
 
Table 5: Interview of Deterioration in Daily Living Activities in Dementia - Confirmatory factor analysis  
Scale N 
Factor 
reliability 
Average variance 
extracted Items Squared multiple correlation 
301 0.87 0.40 01 Washing oneself 0.661 
   02 Making tea or coffee 0.519 
   03 Dressing 0.697 
   04 Combing hair and brushing teeth 0.660 
   05 Eating 0.376 
   06 Using the toilet 0.522 
   07 Shopping 0.215 
   08 Using the telephone 0.353 
   09 Preparing a meal 0.257 
   10 Cleaning house or doing repair work 0.335 
Performance 
 
   11 Handling finances 0.021 
301 0.66 0.39 01 Washing oneself 0.840 
   02 Making tea or coffee 0.236 
   03 Dressing 0.876 
   04 Combing hair and brushing teeth 0.923 
   05 Shopping 0.000 
   06 Using the telephone 0.003 
   07 Preparing a meal 0.001 
   08 Cleaning house or doing repair work 0.051 
Initiative 
 
   09 Handling finances 0.196 
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Concurrent validity  
We found no correlations between the IDDD scales and cognition performance 
scores (r<0.17 for MMSE and ADAS-cog, table 6). Furthermore, the IDDD perform-
ance and initiative scale both correlated very weakly with the carer-rated ADCS-ADL 
score (r<0.24) and were not associated with the PRPP performance test of a daily 
activity (r<0.1). In addition, we found no association between the ADCS-ADL and the 
ADAScog. Correlations of the MMSE were moderate with the PRPP and weak with 
the ADCS-ADL (table 6).  
 
Table 6: Correlations between activities of daily living scales and related scores (Pearson coefficient) 
 Study IDDD-Performance IDDD-Initiative ADSC-ADL PRPP 
Activities of Daily Living   N r N r N r N r 
ADCS-ADL, carer-rated DD 154 -0.230* 154 -0.231*     
PRPP, performance test Fr 107 -0.016 107  0.099     
Cognition          
MMSE, performance test Fr/DD 278 -0.167* 279 -0.050 148 0.290* 120 0.378* 
ADAS-cog, performance test DD 149  0.099 150  0.015 140 -0.134   
IDDD= Interview of Deterioration in Daily Living Activities in Dementia 
ADCS-ADL=Alzheimer’s Disease Cooperative Study Activities of Daily Living Inventory  
PRPP=Perceive, Recall, Plan and Perform System of Task Analysis  
MMSE=Mini Mental State Examination  
ADAS-cog=Alzheimer’s Disease Assessment Scale cognitive 
*p<0.01  
 
 
Discussion 
 
Following standardised procedures of translation, we could provide a German IDDD 
version equivalent to the Dutch instrument. Piloting revealed that carers did under-
stand the questions well and that data collection can be optimised by checking the 
responses directly after administration.  
Descriptive IDDD data indicated a moderate initiative to perform activities of daily 
living and a minor need of assistance in a pooled sample of 301 community dwelling 
people with mild to moderate dementia from two multi-centre trials including ten 
study-sites in total. For both IDDD scales, initiative and performance, bottom and ceil-
ing effects were very low (< 5 %) and internal consistency was good (α>0.7).  
Based on our findings on the construct validity of the IDDD, we advocate for a four 
factor solution, because even though each of the four new scales consisted of fewer 
items, the Cronbach alpha values were excellent. The indices for a better fit of the 
four factor model as well as the excellent internal consistency suggest that the clini-
cally established differentiation between instrumental and basic ADL is confirmed by 
our factor analysis.  
Cognition as measured with the MMSE or ADAS-cog did not correlate with the IDDD 
scales (r<0.17). These findings are in contrast to former studies. The first version of 
the IDDD correlated highly with the Cambridge Cognitive Examination (Roth et al. 
1986) in a sample of 30 community dwelling person with mild to moderate dementia 
(r=-0.77, p<0.01; Teunisse and Derix, 1991). However, this former IDDD version in-
cluded additional items of cognitive and communicational functions such as finding 
way in and outside the house, finding things, reading, writing, verbal expressing and 
starting conversation. Bouwens and colleagues (2009) found in a sample of 442 per-
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sons with Alzheimer’s disease (MMSE: 19) a moderate correlation (r=-0.60; p<0.01) 
between the MMSE and the Blessed Dementia Scale (BDS; Erkinjuntti et al., 1988). 
The BDS comprises only four ADL items (eating, dressing, continence and household 
tasks) and seven items of cognitive functioning in everyday life (coping with small 
sums of money, remembering short list of items, finding way about indoors and about 
familiar streets, interpreting surroundings, recalling recent events and tendency to 
dwell in the past). These results suggest that ADL constructs are heterogeneous. A 
precise definition is needed for a thorough evaluation of the association between 
cognition and daily functioning in AD.  
 
The low correlations between the IDDD performance scale and the PRPP may have 
two reasons. (1) The PRPP measured the number of mistakes made in the perform-
ance of instrumental and not of basic activities of daily living. This was because pa-
tients never chose activities like dressing or bathing to demonstrate for video taping, 
while the original 11-items IDDD performance scale covered also these basic activi-
ties. However, the assumption that the PRPP would significantly correlate with the 
IDDD performance subscale limited to instrumental ADL could not be confirmed 
(r=0.008; p=0.932). (2) Also, the comparison of the IDDD and the PRPP performance 
scales included the contrast of a carer’s estimation of the patient’s need of assistance 
and an assessor’s rating of a concrete task performance. The first can be influenced 
by the carer’s mood, attitude, knowledge or memory. The second might be biased by 
the patient’s mental capacity possibly changing day by day or by special motivation 
when being video taped. So the fact that the carer’s rating of the need of assistance 
in everyday functioning for the last seven days is different to a patient’s short-term 
performance of an everyday task when being videotaped seemed to be the main 
reason for the low correlations between the IDDD and the PRPP. 
The IDDD scales demonstrated low correlations with the ADCS-ADL score (r<0.24), 
although both instruments are carer-rated. Reasons might be that the ADCS-ADL did 
not cover the IDDD item handling finances but additionally records items on commu-
nication (reading, writing, making conversation, discussing current events), on social 
interaction (watching TV, doing games or hobbies, keeping appointments, can be left 
alone, travelling outside home) and on two further items (walking and finding belong-
ings). To test this assumption we selected the basic ADL items and the household 
ADL items of the ADCS-ADL and correlated these two new ADCS-subscales with the 
two new IDDD performance subscales. We found highly significant correlations be-
tween the ADCS-basic-ADL and IDDD-performance-basic-ADL scores (r=0.549; 
p<0.001) and between ADCS-household-ADL and IDDD-performance-instrumental-
ADL scores (r=0.646; p<0.001).  
 
Our findings are in line with reviews on assessment instruments in dementia research 
stating that ADL instruments are heterogeneous on item level and in their correlations 
with measures of cognition. Furthermore, ADL measurements differ in their respon-
siveness to drugs and psychosocial interventions depending on the state of dementia 
(Sikkes et al., 2009; Bouwens et al., 2009; Voigt-Radloff and Hüll, 2011; Gauthier et 
al., 2010; Desai et al., 2004). Low correlations of cognition not only with the IDDD but 
also with the other ADL measurements (PRPP; ADCS-ADL; table 6) emphasize the 
conceptual differences between these constructs. Cognitive decline can result in a 
reduced performance of cognitively challenging daily activities but must not directly 
lead to the deterioration of routine activities of daily living such as basic ADL and fa-
miliar household chores. On the other hand, a decline in initiative may drastically re-
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duce ADLs in patients with good cognitive test results. We therefore advocate for a 
precision of ADL measurement in AD. The IDDD has been shown to be able to 
measure the impact of non-pharmacological treatment aiming at the stabilisation of 
familiar routine activities. The presented empirical data of the German IDDD support 
a four factor model distinguishing initiative and performance as well as basic and 
household activities of daily living. Separate analyses of these subscales seem to be 
appropriate in further trials of non-pharmacological interventions. A further broaden-
ing of the IDDD would be necessary to cover the full range of daily functioning. 
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Abstract 
 
Background: The aim of this study is to evaluate aspects of inter-rater reliability of 
the Perceive, Recall, Plan and Perform (PRPP) System of Task Analysis for assess-
ing daily functioning of home dwelling dementia patients.  
 
Method: Videotaped recordings of 30 German patients with dementia performing a 
relevant daily task in their own homes were scored independently by 10 Dutch PRPP 
trained occupational therapists, randomly selected from a pool of 25. Intra-class cor-
relations (ICC) (one-way single measure) were calculated for PRPP Stage One inde-
pendence score, and PRPP Stage Two information processing scale, quadrant-
scales, and sub-quadrant-scales from a total of 300 PRPP scores.  
 
Results: ICCs for Stage One PRPP independence score are good to excellent (0,63; 
0,94) for both individual rater and test reliability. The Stage Two PRPP total score 
shows moderate correlations (0.46) for the single rater absolute agreement and ex-
cellent agreement (0,90) for test reliability. The four quadrant scale scores of the 
PRPP show limited single rater absolute agreement (0,37-0,39) but excellent average 
test agreement (0,85-0,87). All sub quadrants of information processing show limited 
single rater absolute agreement (0,26-0,38) and good to excellent average test 
agreement (0,78-0,86). This suggests that the PRPP total is reliable in assessing in-
formation processing during activity performance in dementia patients. 
 
Conclusions: The PRPP is a reliable measure to evaluate individual performances 
of routines and tasks in community living dementia patients by multiple raters. Future 
research should address reliability and validity features of the PRPP for dementia 
patients with incorporation of criterion referenced test characteristics.  
 53 
Background 
 
The world prevalence of dementia has recently been estimated at 24.3 million peo-
ple. This is expected to double over the next 20 years [1]. Services that increase per-
formance abilities and well-being in both patients and caregivers are required [2-4]. 
Decline in memory and executive functions are characteristics of the degenerative 
process in dementia. Disabilities in performing daily tasks are the most important 
reason for the need of care including nursing home placement and are a burden to 
caregivers and society [5].  
Tailor-made, individualized, multi-component interventions that are aimed at improv-
ing daily functioning and quality of life for both patient and caregiver are shown to be 
most effective in the home setting [6-10]. To tailor interventions to individual needs it 
is important to know the client’s ability to perform activities and their relationship to 
disturbances in the specific cognitive processes that underpin particular task per-
formance. Neuro-psychological tests have a low ecological validity and do not ade-
quately predict difficulty in daily functioning within the home context [11]. This is why 
sensitive instruments for measuring every day functional abilities are very important 
in dementia care [12-13]. Observation of the performance of daily activities within the 
home context gives unique information about the influence cognitive disturbances 
have on daily life. These assessments form the base for effective treatment interven-
tions.  
There are several reliable and valid observation instruments available to the occupa-
tional therapist for this purpose, such as the Assessment of Motor and Process Skills 
[14-17] and the Arnadottir OT-ADL neurobehavioral evaluation [18-20]. Usage de-
pends on the type of activities a patient prefers to perform. The AMPS mainly con-
sists of standardised household tasks and some other standardised instrumental ac-
tivities of daily living, and measures quality of performance in motor and process 
skills. The A-ONE observes primary self care tasks, and measures levels of inde-
pendence and related cognitive dysfunctions. The A-ONE has a ceiling-effect be-
cause of the lack of complexity in tasks. In both instruments the observed activities 
are standardised which may have the disadvantage that the whole task or the criteria 
to perform it do not fit to the clients’ routines.  
For dementia patients it is highly important to perform meaningful activities they are 
motivated for and in the routines and context they are familiar with. These compo-
nents add to their quality of life [9-10, 21]. Therefore, the Perceive, Recall, Plan and 
Perform system (PRPP) seems an instrument with potential to assess dementia pa-
tients in the home environment because it enables the patient to choose activities 
individually based on preferences and needs [22]. The PRPP examines errors and 
the effectiveness of cognitive information processing in the performance of self-
chosen tasks.  
Psychometric properties of the PRPP for traumatic brain injury, learning difficulties, 
chronic pain and schizophrenia are evaluated in small groups and show adequate 
outcomes on content validity, construct validity, internal consistency, concurrent va-
lidity, inter-rater reliability, intra-rater reliability and responsiveness [23-26]. However, 
no data are available for the use of PRPP in older people with dementia, although 
this target group of patients needs a tailor made assessment to evaluate their per-
formance in familiar daily activities in their own context. Inter-rater reliability is an im-
portant feature of measurings that assess performance of abilities in daily activities 
by observation. Criterion referenced measures incorporate the variability in three foci; 
the demands of the task, the capacity of the person to perform that task; and the con-
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text of performance and therefore, have high ecological validity. However, they have 
the disadvantage that absolute inter-rater agreement is hard to achieve [24].  
Hence, the objective of this study is to evaluate whether the PRPP assessment has 
reliable standardisation criteria that are consistently used for the assessment of per-
forming familiar daily tasks in community dwelling dementia patients by multiple rat-
ers.  
 
 
Methods 
 
Patients 
PRPP baseline data of the WHEDA trial were used in this study. This German multi-
center randomised controlled trial evaluated the effectiveness of community occupa-
tional therapy for dementia patients and their caregivers. The design of the WHEDA 
study has been published in 2009 [26]. Inclusion criteria of participants were: Mild to 
moderate dementia of the type Alzheimer's disease or mixed type; MMSE ranging 
from 10 to 24; People dwelling at home either together with their primary caregiver or 
the primary caregiver provides care at least twice a week. People with a Geriatric 
Depression Scale score (GDS 30) > 12, in major need of nursing care, with unstable 
medical conditions or severe behavioural disturbances were excluded to establish a 
homogenous group with a focus on performance abilities [26].  
 
Raters 
All Dutch occupational therapists that had completed a PRPP assessment course 
(N=79) were asked by e-mail to participate in this inter-rater reliability study. 25 were 
motivated to participate and agreed to score independently the PRPP videos at 
home. No additional inclusion criteria for raters were used. Dutch PRPP trained oc-
cupational therapists were chosen as raters instead of German PRPP trained occu-
pational therapists because of the availability of a PRPP alliance in the Netherlands 
and the use of the official translated (from English) Dutch PRPP scoring forms which 
are not available in German. 
 
Measurements 
Patient characteristics were measured within the WHEDA trial. The baseline charac-
teristics regarding sex, age, education, years since onset dementia, and baseline 
outcomes measured with the interview of deterioration in daily living activities in de-
mentia (IDDD), Dementia Quality of Life Instrument (DQoL), Short form of the SF-36 
measuring health status (SF-12), Geriatric depression scale (GDS), and the Mini 
Mental State Examination (MMSE) will be presented.  
The PRPP system of task analysis is a two-stage, criterion referenced measure in-
strument that examines the effectiveness of cognitive information processing in per-
forming meaningful tasks according to individualized standards (the criterion) set by 
the client’s particular situation. Stage One incorporates a task analyses procedure, in 
which an observed familiar task is subdivided into all relevant steps, and measures 
types of mistakes, e.g. being inaccurate, repeat steps, omit steps, and wrong timing, 
in the performance of steps in the chosen task. Level of independence in performing 
the task can be calculated in Stage One by dividing the amount of wrongly performed 
steps by the amount of all steps of the task. Stage Two consists of the analyses of 
information processing and incorporates 34 items divided in the subscales Perceive, 
Recall, Plan, and Perform. Items cover information processing aspects such as at-
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tending; sensing; discriminating; recalling facts, schemes and procedures; mapping; 
programming; evaluating; initiating; continuating; and controlling. Each item is rated 
on a 3-point scale (inadequate, inconsistent, adequate). Both therapist and patient 
decide together which task is relevant to observe given the performance difficulties in 
meaningful activities as expressed by the patient.  
The PRPP was scored using the Dutch PRPP assessment scoring form including 
Stage One independent score and Stage Two information processing items. For 
Stage One the activity steps to be scored were pre-set by the raters from the 
WHEDA trial based on individual performance of the filmed task according to the rou-
tines of the patient. Within the WHEDA trial each patient performed two self-chosen 
tasks out of 29 pre-set meaningful tasks. Scoring criteria were used according the 
PRPP manual which is instructed in the PRPP assessment course [23].  
 
Procedures 
30 video footages out of 258 baseline performances of two self chosen daily tasks in 
the home environment by a dementia patient were randomly selected by a research 
assistant who was blinded for patient identity and performance characteristics. Exclu-
sion criteria for video footages were duration > 15 minutes, comments from WHEDA 
rater on insufficient visibility of the video and/or comments on therapist’s inadequate 
influence on performance. An independent statistician randomized the videos by rat-
ers in such manner that each of the 25 raters scored 12 videos and that each of the 
30 videos was scored by 10 different raters. This resulted in 300 cases and provides 
a good power to establish inter-rater test reliability (ICC > 0.70) [27]. 
Raters were provided with cd-roms with the 12 video films and scoring forms and 
were instructed to rate independently at home and not discuss findings with other 
raters. Independence of raters was enhanced by providing each rater with a unique 
set of 12 videos.  
 
Statistical analyses 
For Stage One independence score and Stage Two sub quadrant scales, quadrant 
scales and whole scale ICCs were computed with SPSS 18. A one way model was 
used for ICC calculation since both raters and video’s were randomly assigned and 
no videos were rated by all raters. Average measure ICCs reflect the consistent use 
of the PRPP standardisation criteria by multiple raters. Scores ≥0.70 will be regarded 
as good inter-rater consistency. 
Single measure ICCs reflect the absolute agreement between raters and are ex-
pected to be fair or moderate. ICC from 0,20 to 0,39 is regarded as fair inter-rater 
reliability, 0.40 to 0.59 as moderate inter-rater reliability, 0.60 to 0.79 as substantial, 
and 0.80 or above as outstanding [28].  
 
 
Results 
 
Patient characteristics  
Table 1 summarizes the characteristics of the 28 dementia patients at the time of the 
video shoot. Recently diagnosed (mean 1.7 year, sd 1.5) mild dementia patients 
(mean MMSE score = 20, sd 2.5) with few to moderate need for assistance (IDDD 
performance mean = 14, sd 10.5) were included in this study.  
All participating raters (N= 25) were occupational therapy practitioners or researchers 
who had been trained in PRPP use. The majority (N= 24 therapists) followed the as-
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sessment course 3 to 1 year prior to this research, only one had been trained 11 
years before. All were experienced occupational therapists in adult health care.  
 
 
Table 1: Characteristics of included patients (N=28) 
Characteristic Mean SD Range 
Male N  
Female N  
12 (42.9%) 
16 (57.1%) 
- - 
Age 76 9 56-87 
Education 
Professional N 
University N 
 
22 (78 %) 
6 (22 %) 
 
- 
 
- 
Years since onset dementia 1,7 1,5 0-5 
MMSE 21,0 2,5 17-24 
GDS 6,0 3,1 0-11 
IDDD 
Initiative 
Performace 
 
19,7 
14,0 
 
10,1 
10,5 
 
0-36 
0-38 
SF-12 
Physical 
Mental 
 
42,4 
46,6 
 
10,8 
10,2 
 
24-62 
16-64 
DQOL overall 3,0 0,7 2-5 
MMSE= Mini Mental State Examination 
GDS= Geriatric Depression Scale 
SF-12 = Short Form of the SF-36 measuring health-status 
DQoL= Dementia Quality of Life Instrument 
IDDD = Interview of Deterioration in Daily Living Activities in Dementia 
 
 
 
Table 2: Inter-rater single measure and average measure reliability of the PRPP 
Items ICC single 95% CI ICC average 95% CI 
Stage One independence score 0.63 0.50-0.76 0.94 0.91-0.97 
Stage Two information processing: whole 0.46 0.33-0.63 0.90 0.83-0.94 
Perceive Quadrant 0.37 0.24-0.54 0.85 0.76-0.92 
Attending 0.32 0.20-0.49 0.83 0.72-0.91 
Sensing 0.31 0.19-0.48 0.82 0.71-0.90 
Discriminating 0.36 0.23-0.53 0.85 0.75-0.92 
Recall Quadrant 0.38 0.25-0.54 0.86 0.77-0.92 
Recalling facts 0.28 0.17-0.45 0.80 0.67-0.89 
Recalling shemes 0.26 0.15-0.43 0.78 0.64-0.88 
Recalling procedures 0.35 0.23-0.52 0.84 0.74-0.92 
Plan Quadrant 0.39 0.26-0.56 0.86 0.78-0.93 
Mapping 0.35 0.22-0.52 0.84 0.74-0.91 
Programming 0.32 0.20-0.49 0.82 0.71-0.90 
Evaluating 0.31 0.19-0.48 0.82 0.70-0.90 
Perform Quadrant 0.39 0.26-0.56 0.87 0.78-0.93 
Initiating 0.29 0.18-0.46 0.80 0.68-0.89 
Continuing 0.31 0.19-0.48 0.82 0.70-0.90 
Controlling 0.38 0.25-0.54 0.86 0.77-0.92 
PRPP=Perceive, Recall, Plan and Perform System of Task Analysis 
ICC= Intra-class correlations 
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Table 2 shows the ICC for Stage One and Stage Two: sub-quadrant scales, quadrant 
scales and whole scale. The ICC for Stage One independence score showed good 
outcomes both for absolute inter-rater agreement as for consistency of test criteria 
standardisation. Stage Two subscales, quadrants and whole scale show good inter-
rater consistency of test criteria standardisation. Stage two subscales and quadrant 
shows fair inter-rater absolute agreement. The whole PRPP information processing 
scale shows moderate absolute agreement. 
 
  
Discussion 
 
This study shows that the PRPP system of task analysis has sufficient inter-rater reli-
ability for the assessment of performance of familiar daily activities in the home con-
text in mild dementia patients and who required little to moderate assistance in per-
forming daily activities. Both the independence score and the information processing 
scale show consistent test use by multiple raters indicating reliable standardisation of 
the PRPP assessment of task analysis. Absolute inter-rater agreement is not ex-
pected to be high in ecologically valid, criterion referenced measures. This is con-
firmed for Stage Two. The absolute agreement between raters for the independence 
score is good. 
The results of this study for Stage Two correspond in general with other studies that 
evaluated inter-rater reliability of the PRPP assessment for other diagnostic groups. 
Nott et al (2009) evaluated inter-rater reliability of Stage Two of the PRPP assess-
ment in two studies with respectively 15 and 5 traumatic brain injury patients who had 
been scored by 3 and 9 raters respectively and found high reliability (single measure 
agreement ICC between 0,51-0,77; test consistency all ICC > 0,8). Nott et all used a 
three-way ICC analyses incorporating the three factors of variability; patients, tasks, 
and raters, which explains the higher ICCs in comparison with the current single ab-
solute agreement outcomes of the current study [24]. Aubin et al (2009) reported 
good (for PRPP total score; 0,77) and moderate (for PRPP quadrant scale scores; 
0,63-0,69) outcomes for inter-rater reliability of the PRPP assessment Stage Two in 
15 schizophrenia patients who were scored by 3 raters on two tasks each using a 
two-way mixed effects model for absolute agreement [25]. This is the first study that 
also looked at inter-rater reliability for Stage One of the PRPP and showed good re-
sults on both absolute inter-rater agreement and standardisation. 
The reliability outcomes for Stage One of the PRPP assessments do show the power 
of the instrument to assess individual performance of routine tasks of dementia pa-
tients in their home context. In the PRPP the necessity for individual choices regard-
ing specific tasks and environmental demands is well recognised and therefore is an 
important tool in assessing ecological valid performance levels in the performance of 
daily tasks. The criterion referenced standardisation of scoring rules is applied con-
sistently by multiple raters as shown in this study for both stages. Therefore, the 
PRPP is an important addition to the available assessment tools for occupational 
therapists treating home dwelling dementia patients.  
A limitation of this study is that only patients with mild dementia who had been diag-
nosed in the last few years were included in the study. Therefore the results on reli-
ability of this instrument cannot be generalised to all dementia patients. However, this 
sample is comparable for mood and quality of life with the Dutch study of Graff (2007) 
in which mild and moderate community dwelling dementia patients were included 
[10].  
 58 
Another limitation of this study regarding Stage One is the use of pre-set task analy-
ses by raters. This meant that the relevant steps of the task were already determined 
and not defined by the raters themselves. This was done to make the ratings compa-
rable for the amount of the single steps of the rated tasks and for the equation of the 
independence score. In routine care each occupational therapist has to perform the 
task analyses for the individual situation and tasks observed which increases variabil-
ity in scoring the PRPP. Future research into Stage One should also evaluate the 
consistency in task analyses standardisation applied by occupational therapists.  
This study was not designed to establish absolute inter-rater agreement on Stage 
Two information descriptors (item) level. To look at inter-rater reliability on item level 
of the PRPP one should take into account all the variability that occurs in PRPP as-
sessment. This means that the design should have enough statistical power, should 
use a nested design in which the variety in tasks, patients, environments, and raters 
are adequately addressed [24] and that all raters should rate all available cases. At 
this stage of PRPP implementation in the Netherlands the required amount of experi-
enced raters were not available to perform such a large study.  
The absolute agreement ICC outcomes for Stage Two are fair (subscales, scales) 
and tend to moderate (scales). These outcomes might be slight underestimates of 
real absolute agreement because of some specific study characteristics. The video 
footages were of German speaking dementia patients living in Germany and filmed in 
their home environments. Although all Dutch raters have sufficient knowledge of the 
German language and culture to rate these performances the influence of a different 
language and less familiar routines in performances need to be taken into account. 
The good consistency outcomes of the PRPP show that the PRPP is a reliable tool to 
be used by multiple raters in several and even less familiar tasks observations.  
In conclusion, this study pertaining to inter-rater reliability of the PRPP for community 
dwelling dementia patients shows that the PRPP is consistent tool used by multiple 
raters and has potentiality to be a good measuring instrument to rate performance of 
patients with mild dementia in a variety of routines and tasks of meaningful daily ac-
tivities in a variety of environments. The criterion referenced standardised PRRP can 
be used to reliably assess “real life” performances according individual standards. 
Future research should focus on other validity and reliability characteristics of the 
PRPP for dementia patients in different stages of the disease, with additional symp-
toms such as depression, and in different living environments. Rasch analyses pro-
cedures could be helpful to address the several variety issues that occur in criterion 
referenced measures.  
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Abstract  
 
Objective: to translate the Dementia Quality of Life Instrument (DQoL) into German 
and assess its construct and concurrent validity in community dwelling people with 
mild to moderate dementia. 
 
Methods: DQoL data of two pooled samples (n=287) were analysed regarding ceil-
ing and bottom effects, internal consistency, factor reliability and correlations with 
corresponding scales on quality of life (QoL-AD and SF-12), cognition (Mini Mental 
State Examination, Alzheimer’s Disease Assessment Scale cognitive), depression 
(Cornell Scale for Depression in Dementia) and activities of daily living (Interview of 
Deterioration in Daily Living Activities in Dementia). 
 
Results: We found no bottom effects (< 2 %), minor ceiling effects (1 to 11 %), mod-
erate to good internal consistency (Cronbachs α: 0.6 to 0.8) and factor reliability (0.6 
to 0.8), moderate correlations with self-rated scales of quality of life (Pearson coeffi-
cient: 0.3 to 0.6) and no or minor correlations with scores for cognition, depression or 
activities of daily living (r < 0.3). The original five factor model could not be confirmed. 
 
Conclusion: The DQoL can be used in dementia research for assessing positive and 
negative affect, feelings of belonging and self-esteem. The findings suggest further 
research to improve the structure of the scales aesthetics, feelings of belonging and 
self-esteem. 
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Introduction 
 
In dementia research, the assessment of quality of life (QoL) is recommended and 
valid instruments are needed in several languages for cross-national studies [1-5]. 
The debate on QoL for people with Alzheimer’s disease refers to Lawton who 
claimed behavioral competence, positive and negative affect, the objective environ-
ment and subjective QoL as determinants of well-being in older adults [6-12]. Empiri-
cal data substantiate that QoL as perceived by people with dementia is moderately 
associated with depressive mood, slightly connected to activity participation but not 
consistently related to behavioral or cognitive disorders [13]. The Hierarchy Model of 
Needs in Dementia relates QoL to the fulfillment of needs in analogy to Maslow 
[14,15]. According to this an assessment of QoL should measure the grade of fulfill-
ment of needs concerning basic physiology, safety, belongingness, esteem and self-
actualization. Instruments measuring QoL in dementia research can be specified by 
(1) the number of measured dimensions, (2) its specificity (generic or disease-
specific), (3) the information source (self-report, carer-rating or staff observation), (4) 
the severity of dementia in the target group (mild, moderate or severe) and (5) the 
housing situation (community or nursing home) [8]. Disease-specific instruments ap-
plied in the community and covering the perspective of patients with mild to moderate 
dementia are urgently needed to evaluate new psychosocial and drug therapies. We 
screened recent reviews on QoL measures [16-20] and found three instruments in 
this area: the Dementia Quality of Life Instrument (DQoL) in four different languages 
[21-26]; the Quality of Life-Alzheimer’s Disease Scale (QoL-AD) in three versions [7, 
27-30] and the DEMQOL in English [31].  
Three reasons argue for applying the DQoL. (1) An international expert panel in de-
mentia research gave a consented recommendation to use the QoL-AD or the DQoL 
for cross-national research [20]. (2) The DQoL was developed with a rigorous de-
mand for the participation of people with dementia [21]. (3) It was already success-
fully used for randomised efficacy studies for psychosocial interventions [32] and may 
gain wide acceptance. This would allow more homogeneous meta-analyses of data 
on psychosocial interventions in Alzheimer’s disease.  
The DQoL consists of 30 items and five scales: positive affect (6 items), negative af-
fect (11 items), feelings of belonging (3 items), self-esteem (4 items), sense of aes-
thetics (5 items) and one global item. Interviewees are asked to rate their frequency 
of affects in the last seven days with 1=never, 2=seldom, 3=sometimes, 4=often, and 
5=very often. The enjoyment of experiences is to be rated with 1=not at all, 2=a little, 
3=somewhat, 4=mostly, and 5=very [21]. The scores of the scales differ depending 
on the number of items. Higher scores indicate better QoL, except in the scale nega-
tive affect. The DQoL was developed specifically to be completed by people with mild 
to moderate dementia. The interview procedure includes three screening questions to 
test the patient’s language comprehension. The patient must give at least two correct 
answers before the interview starts. 96 of 99 US-American people with dementia 
(MMSE ≥ 13) were able to respond appropriately to all DQoL questions with moder-
ate to high internal consistency (0.67 to 0.89), with good two-week test-retest reliabil-
ity (0.64 to 0.90) and without significant differences in patient groups with mild versus 
moderate dementia (cut off MMSE=17) [21].  
The purpose of our study was to translate the DQoL into German and evaluate its 
construct validity including the internal consistency and concurrent validity in two 
samples of community dwelling older persons with mild to moderate dementia.  
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Methods 
 
Design 
Data were collected within two multi-centre RCTs on community occupational therapy 
for people with mild to moderate dementia funded by the German Federal Ministry of 
Health. The WHEDA trial was coordinated in Freiburg and included seven sites and 
141 participants [33]. Eligible participants were diagnosed as having Alzheimer’s dis-
ease; had a MMSE score between 14 and 24, no major depression and no severe 
behavioral disturbances; lived in the community; gave informed consent; and a pri-
mary carer was available at least twice a week. The ERGODEM trial from Dresden 
comprised three sites and 160 patients [34]. The criteria for the eligibility to partici-
pate in the study were the same as in the WHEDA trial with two exceptions. Patients 
with vascular dementia according to DSM-IV were also included and the range of the 
MMSE score was broader (12-26). Ethical approval was given by the Medical Ethics 
Committee of the University Hospital Freiburg and the Ethics Committee of the Fac-
ulty of Medicine at the Dresden University of Technology. Trials were registered at 
the German Trial Register. 
 
Measurement Instruments 
As constructs corresponding to the DQoL, we assessed the patient’s generic health-
related QoL, mood, activities of daily living, and cognition using established meas-
urement instruments (table 1). 
 
Table 1: Measurement scheme  
Variables Freiburg Dresden 
Demographics    
Age x x 
Gender x x 
Relation to carer x x 
Quality of Life   
DQoL, disease-specific, self-rated x x 
QoL-AD, disease-specific, self-rated  x 
QoL-AD, disease-specific, carer-rated  x 
SF-12, generic, physical subscale, self-rated x  
SF-12, generic, mental subscale, self-rated x  
Mood/depression   
CSDD mood/depression carer-rated x  
Activities of Daily Living    
IDDD, carer-rated x x 
Cognition   
MMSE, performance test x x 
ADAS-cog, performance test  x 
DQoL= Dementia Quality of Life Instrument 
QoL-AD=Quality of life in Alzheimer's disease instrument  
CSDD=Cornell Scale for Depression in Dementia 
IDDD=Interview of Deterioration in Daily Living Activities in Dementia 
ADAS-cog=Alzheimer’s Disease Assessment Scale cognitive 
 
The Quality of life in Alzheimer's disease instrument (QoL-AD) is a 13-item question-
naire designed for measuring the QoL of patients with dementia and their caregivers. 
It includes assessments of the individual's physical condition, mood, memory, rela-
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tionships with friends and family, functional abilities, financial situation and an overall 
assessment of life quality. Individuals respond on a four point Likert-scale (1=poor, 
4=excellent). The total score ranges from 13 to 52, with higher scores indicating 
greater QoL. Studies on psychometric properties demonstrated good reliability and 
validity of the QoL-AD for individuals with mild to moderate dementia [7, 35]. 
The SF-12 is a broadly established generic self-assessment evaluating health-related 
QoL. The instrument generates a mental and a physical score from 12 weighted 
items with response categories varying from dichotomous to six-point scales using a 
complex algorithm. Higher scores indicate better health status. Metric properties are 
excellent [36].  
The Cornell Scale for Depression in Dementia (CSDD) records 19 symptoms within 
the domains (1) mood and related signs, (2) behavioral disturbance (3) cyclic function 
and ideational disturbance and (4) physical signs [37]. Symptoms are rated as “ab-
sent”, “mild or intermittent” or “severe”. Scores range from 0 to 38. Lower scores indi-
cate less depressive characteristics, values above 8 indicate a depressive disorder. 
Correlations with other depression measurements ranged from r=0.70 to 0.93. Inter-
nal consistency and inter-rater reliability were high (Cronbach's alpha=0.81; 
ICC=0.84) [38, 39]. 
The Performance Scale of the Interview of Deterioration in Daily Living Activities in 
Dementia (IDDD) records the need for assistance in the performance of 5 basic ac-
tivities and 6 instrumental activities of daily living [40]. Items are rated from 0 to 4 with 
a sum score from 0 to 44. A higher score indicates higher need for assistance. The 
IDDD demonstrated great internal consistency (Cronbach's alpha=0.99), reproducibil-
ity (ICC=0.94), interrater reliability (ICC=0.74) and significant differences between 
groups of patients with mild cognitive impairment and patients with dementia [40, 41].  
The Mini Mental State Examination (MMSE) and the Alzheimer’s Disease Assess-
ment Scale cognitive (ADAS-cog) are established tests of cognitive performance [16]. 
 
Procedures 
Our procedures were in line with the latest guideline on cross-cultural translation and 
validation, which summarized relevant review studies and previous guidelines on this 
topic [42]. For two reasons we used the Dutch DQoL version [26] as source. Our 
Dutch-German research group investigated the impact of complex interventions on 
important patient-oriented outcomes when transferred from the Netherlands to Ger-
many. So we were interested in broadening the Dutch and German understanding of 
the concepts underlying the DQoL construct. Furthermore, we deepened our under-
standing of the meaning and the conceptual equivalence of terms using primarily the 
Dutch source and secondarily the English original version [21]. In all phases, we used 
English as common language to explore the meaning of terms in the source and tar-
get languages and to resolve inconsistencies by using descriptions of intended 
meanings.  
Forward translations: A psychologist and an occupational therapist independently 
translated the instructions, items and response formats from the Dutch source lan-
guage to the German target language, additionally considering the English original 
version. Both translators were native German speakers, excellent in Dutch and fluent 
in English. One of them is living in the Netherlands and working in Germany. The 
second translator is living in Germany, but studied psychology in the Netherlands for 
five years.  
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Synthesis of forward translations: The project manager compared the forward-
translated versions, highlighted ambiguities and discrepancies in a synthesised ver-
sion and achieved an agreement with the translators by discussion. 
Backward translations: Two Dutch occupational therapists independently translated 
the preliminary German version back to Dutch. The Dutch translators were excellent 
in German and fluent in English, one of them was formerly concerned with translation 
issues in research [43].  
Synthesis of backward translations: The Dutch translators compared the two back-
ward-translated Dutch versions and highlighted discrepancies. For the coordinating 
project manager, they transferred the Dutch discrepancies to the German version 
and explained it with English comments using single Dutch words when necessary. 
All four translators and the project manager discussed this synthesized version con-
sidering all highlighted ambiguities and discrepancies of the forward and backward 
translations. Again, agreement on the final version was achieved by discussion.  
Pilot-testing: The assessors involved in the WHEDA trial attended a seminar on 
DQoL application and interviewed patients with mild to moderate dementia. In a writ-
ten cognitive debriefing [44] on the response process, the assessors were asked to 
list aspects facilitating or hindering the DQol application. 
Full psycho-metric testing: Patients were interviewed at home with the DQoL and the 
SF-12 (WHEDA-study) or with the DQoL and the QoL-AD at the study sites (ER-
GODEM-study). The primary caregivers completed the socio-demographic question-
naire, the QoL-AD-carer, the CSDD and the IDDD in a separate room. Trained study 
staff (psychiatrists, psychologists or study nurses) collected data of the MMSE and 
ADAS-cog at the study site in the same week. At the coordinating clinical trial centres 
questionnaires were checked for completeness and plausibility, typed in, checked 
again for typing errors and analysed. 
 
Statistical analysis 
The values of the DQoL scales were calculated and reported with means, standard 
deviation and frequency of best and worst possible values (ceiling and bottom ef-
fects). Internal consistency was indicated by Cronbach's alpha. Confirmatory factor 
analysis was applied to evaluate scale structures. Pearson correlation coefficients 
were calculated for scores of the DQoL scales and scores of the MMSE, ADAS-cog, 
CSDD, IDDD, SF-12 and QoL-AD. Because of the inflation of alpha-error, only corre-
lations with high significance (p <0.01) were considered. 
 
 
Results 
 
Translation  
The introductory instructions for the patient were reformulated into a more plain lan-
guage, e. g. we used the term answers instead of response scale. There were some 
minor discrepancies in the wording of questions such as “How much did you enjoy to 
look at vs watch vs observe birds”? Furthermore, it was a challenge to capture the 
meaning of affects represented by only one word. Examples were “How often did you 
feel uneasily vs anxiously vs afraid”? or “How often did you feel irritated vs angry”? 
We found agreement also through ranking the Dutch, German and English words by 
the intensity of the expression. 
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Pilot-testing 
14 assessors provided cognitive debriefing data of 21 DQoL interviews. In one case 
one item response was missing. In 12 cases (57%), the assessors had to explain 
questions again or to encourage patients to continue, but all interviews could be 
completed, except one (5%) where the patient felt overstrained. The collection of 
DQoL data was feasible in patients with mild to moderate dementia, when trained 
interviewers adapted to the patients’ individual capability. We concluded that the in-
terviewers should be well trained and used to interviewing people with cognitive im-
pairments, but that a change in the wording of instructions, questions or response 
formats was not necessary. 
 
Descriptive results 
Data could be pooled because analyzed samples of Freiburg (N=136) and Dresden 
(N=151) did not differ significantly (table 2). Consistently on each scale, descriptive 
data demonstrate values in the direction of positive QoL (table 3). This indicates that 
the majority of patients seldom experienced negative affects, often positive affects 
and mostly enjoyment. Minor ceiling effects were found in the scales negative affect 
(8.7 % with best scale values) and feeling of belongings (10.8 %). 
 
Table 2: Baseline characteristics  
 Freiburg (FR) Dresden (DD) p Total sample 
N 136 151  287 
MMSE, mean (SD) 20.5 (2.9) 21.0 (3.9) 0.320 20.8 (3.5) 
Age, years (SD) 78.4 (6.3) 76.5 (7.4) 0.051 77.3 (7.2) 
Gender, female (%) 77 (57 %) 86 (57 %) 0.954 163 (57 %) 
Spouse as primary carer (%) 78 (57 %) 97 (65 %) 0.205 175 (61 %) 
MMSE=Mini Mental State Examination 
 
 
Table 3: Dementia Quality of Life Instrument - descriptive data  
 N Scale values 
  
No. of 
items 
Mean of 
items Mean SD Median Bottom effectsb Ceiling effectsb 
Overall (1-5)a 287 1 3.05 3.05 0.73 3 4 (1.4%) 11 (3.8%) 
Aesthetics (5-25)a 287 5 3.70 18.52 4.07 19 0 (0.0%) 13 (4.5%) 
Positive affect (6-30)a 287 6 3.56 21.36 4.61 22 2 (0.7%) 3 (1.0%) 
Negative affect (55-11)a 287 11 1.91c  20.97 7.29 20 0 (0.0%) 25 (8.7%) 
Self Esteem (4-20)a 287 4 3.50 14.01 2.99 14 0 (0.0%) 5 (1.7%) 
Feelings of belonging (3-15)a 287 3 3.89 11.68 2.23 12 0 (0.0%) 31 (10.8%) 
a Range: negative to positive; b No. of cases with worst/best scale values; c item with reverse polarity 
 
 
Construct validity  
Cronbach’s alpha indicated good internal consistency for the scales positive affect 
and negative affect (α > 0.8) and moderate consistency for aesthetics, self esteem 
and feelings of belonging (α > 0.6 and < 0.7). Cronbach’s alpha > 0.7 were found for 
the scale aesthetics when eliminating the item listening to music and for the scale self 
esteem when eliminating the item makes own decisions (table 4). These items also 
showed the least correlations with scale values within the confirmatory factor analysis 
(table 5). Furthermore the factor analysis revealed that factor reliability for positive 
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affect and negative affect is higher (0.84) than for the other scales (<0.7). Average 
variance extracted is < 0.4 for all scales, except for positive affect (0.47). Overall, the 
confirmatory factor analysis found a bad fit indicated by a significant difference be-
tween the original five factor model of the DQoL and the correlations actually found in 
our sample (χ2 = 888.6, df = 391, p<0.001). 
  
Table 4: Dementia Quality of Life Instrument - internal consistency  
Scale N Cronbachs 
alpha 
Items Mean item 
(SD) 
Corrected item-to-
scale-correlation 
Cronbachs alpha 
without item 
285 0.669 01 Listening to music  3.58 (1.24) 0.205 0.711 
  02 Listening to sounds of nature  3.61 (1.28) 0.575 0.543 
  03 Watching animals or birds 3.78 (1.30) 0.479 0.591 
  04 Looking at colourful things 3.82 (1.19) 0.454 0.605 
Aesthetics 
 
  05 Watching clouds or sky 3.76 (1.17) 0.423 0.619 
285 0.843 13 Found something that made them laugh 3.34 (1.10) 0.548 0.832 
  15 Happy 3.63 (1.04) 0.659 0.809 
  18 Cheerful 3.53 (1.00) 0.733 0.795 
  21 Content 3.89 (0.97) 0.587 0.823 
  23 Hopeful 3.54 (1.07) 0.579 0.826 
Positive 
affect 
 
  28 Jokes and laughs with others 3.43 (1.01) 0.634 0.814 
285 0.843 07 Embarrassed 1.64 (0.93) 0.370 0.841 
  14 Afraid 1.61 (1.03) 0.533 0.829 
  16 Lonely 1.80 (1.11) 0.444 0.836 
  17 Frustrated  1.84 (1.04) 0.588 0.824 
  19 Angry 1.99 (0.99) 0.595 0.824 
  20 Worried 2.41 (1.19) 0.489 0.833 
  22 Depressive 1.87 (1.05) 0.556 0.827 
  24 Nervous 2.18 (1.21) 0.529 0.829 
  25 Sad 2.11 (1.10) 0.657 0.818 
  26 Irritated 1.80 (0.98) 0.441 0.836 
Negative 
affect 
 
  27 Anxious 1.75 (1.05) 0.547 0.828 
286 0.678 09 Feels confident 3.52 (1.09) 0.580 0.526 
  10 Satisfied with self 3.57 (1.06) 0.541 0.557 
  12 Accomplished something  3.41 (0.95) 0.438 0.627 
Self  
Esteem 
  29 Makes own decisions 3.51 (1.11) 0.304 0.715 
286 0.617 06 Felt useful 3.56 (1.08) 0.343 0.652 
  08 Felt lovable 3.97 (1.04) 0.489 0.420 
Feelings of 
belonging 
   11 Felt people liked you 4.14 (0.80) 0.478 0.477 
 
 
Concurrent validity 
The analysis of concurrent validity revealed moderate correlations (r > 0.43) for the 
DQoL overall item, positive affect and self-esteem with both the SF-12 mental scale 
and the QoL-AD score (table 6). Negative affect was moderately associated only with 
the SF-12 mental scale (r > -0.63); and feelings of belonging only with the QoL-AD 
score(r > 0.53). Carer-rated scales of patient’s QoL, depression or activities of daily 
living demonstrated no or minor correlations with DQoL scales (r < 0.25). Perform-
ance tests of patient’s cognition did not correlate with the DQoL (r < 0.18).  
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Discussion 
 
In our cross-national validation study on the Dementia Quality of Life Instrument 
(DQoL), the standardised procedure of forward and backward translation resulted in 
a German version equivalent to the Dutch and the English DQoL. Piloting revealed 
good feasibility of the new version, when applied as interview by experienced asses-
sors. However, in the study phase assessors reported that (1) sometimes patients 
with mild dementia perceived questions of the scale aesthetics as inappropriate be-
cause they were too narrowed to the experience with nature and that (2) a few pa-
tients with moderate dementia had a reduced understanding for some questions 
though they correctly answered the screening questions.  
 
Table 5: Dementia Quality of Life Instrument - Confirmatory factor analysis  
Scale N Factor reliability Average variance extracted Items 
Squared multiple 
correlation 
285 0.69 0.33 01 Listening to music  0.081 
   02 Listening to sounds of nature  0.512 
   03 Watching animals or birds 0.409 
   04 Looking at colourful things 0.357 
Aesthetics 
   05 Watching clouds or sky 0.263 
285 0.84 0.47 13 Found something that made them laugh 0.321 
   15 Happy 0.586 
   18 Cheerful 0.614 
   21 Content 0.515 
   23 Hopeful 0.413 
Positive  
affect 
   28 Jokes and laughs with others 0.413 
285 0.84 0.34 07 Embarrassed 0.162 
   14 Afraid 0.318 
   16 Lonely 0.249 
   17 Frustrated  0.406 
   19 Angry 0.393 
   20 Worried 0.290 
   22 Depressive 0.427 
   24 Nervous 0.297 
   25 Sad 0.560 
   26 Irritated 0.247 
Negative  
affect 
   27 Anxious 0.335 
286 0.69 0.37 09 Feels confident 0.470 
   10 Satisfied with self 0.576 
   12 Accomplished something  0.343 
Self  
Esteem  
   29 Makes own decisions 0.119 
286 0.64 0.38 06 Felt useful 0.336 
   08 Felt lovable 0.442 
Feelings of 
belonging 
   11 Felt people liked you 0.342 
 
However, the original five factor model of the DQoL could not be confirmed. Only the 
scales positive affect and negative affect demonstrated high factor reliability and in-
ternal consistency (r > 0.8). This is partly congruent to the factor analysis of Ready et 
al. confirming a three-factor solution corresponding to positive affect, negative affect 
and aesthetics [45]. In our sample, aesthetics was weakly correlated to QoL instru-
ments (QoL-AD: r = 0.27; SF-12 mental: r = -0.102). The item listening to music nei-
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ther statistically fits to aesthetics nor is the content consistent to the other items 
which record the enjoyment of nature (table 4 and 5). The scales feeling of belong-
ings and self esteem were associated with other QoL instruments (table 6) and dem-
onstrated a moderate internal consistency and factor reliability (tables 4 and 5). 
 
Table 6: Dementia Quality of Life Instrument and related scores at baseline - Pearson correlations coefficient  
 Study N DQoL-Scales 
   Overall Aesthetics Positive 
affect 
Negative 
affect 
Feelings of 
belonging 
Self-
esteem 
Quality of Life         
QoL-AD, self-rated (13-52)a DD 150 0.595**  0.270** 0.575** -0.384** 0.530** 0.567** 
QoL-AD, carer-rated (13-52)a DD 147 0.139  0.150 0.220* -0.240* 0.221* 0.226* 
SF-12-physical, self-rated (0-100)a FR 112 0.391**  -0.009 0.229** -0.213 0.250* 0.277* 
SF-12-mental, self-rated (0-100)a FR 112 0.435**  -0.102 0.464** -0.625** 0.267* 0.489** 
Depression         
CSDD, carer-rated (38-0)a FR 122 -0.252*  0.135 -0.263* 0.170 -0.225 -0.183 
Activities of Daily Living          
IDDD, carer-rated (0-44)a FR/DD 285 0.010  -0.084 -0.027 -0.083 -0.083 -0.119 
Cognition         
MMSE, performance test (0-30)a FR/DD 267 -0.007  -0.091 0.054 -0.012 0.026 0.173* 
ADAS-cog, performance test (85-0)a DD 151 -0.103  -0.098 -0.166 -0.030 -0.122 -0.125 
DQoL= Dementia Quality of Life Instrument 
QoL-AD=Quality of life in Alzheimer's disease instrument  
CSDD=Cornell Scale for Depression in Dementia 
IDDD=Interview of Deterioration in Daily Living Activities in Dementia 
MMSE=Mini Mental Stat Examination 
ADAS-cog=Alzheimer’s Disease Assessment Scale cognitive 
a Range: negative to positive; * p<0.01; ** p<0.001 
 
 
Descriptive DQoL data indicated good QoL in our sample of 287 community dwelling 
people with mild to moderate dementia. We found only minor ceiling effects in the 
scales negative affect and feeling of belongings.  
 
Correlations between DQol scales and depressive symptoms as reported by Suzuki 
et al. [23, 24] (r = 0.4 to 0.6) could not be found in our sample (r < 0.27, table 6). 
However, in the Japanese sample depression was self-rated. In contrast in our sam-
ple, all carer ratings on patient’s QoL, depression and activities of daily living were 
poorly correlated with DQoL scores as self-rated by the patient (table 6) confirming 
findings of low associations between self- and carer-rated QoL [13].  
Several limitations in the measurement of QoL are discussed in dementia research. 
Patient self-reports can be biased by depression and anosognosia and by distur-
bances of attention, language skills or orientation [6, 8-10, 46, 47]. Carer reports can 
also be biased. Carers with increased burden or depression rated the patients’ QoL 
lower than the patients themselves did. Furthermore, carers rated the QoL of patients 
with challenging behaviours worse than the patients themselves did [13]. Conse-
quently, measurement schemes of QoL in dementia should control for possibly con-
founding influences. The limitation of our study was that we could not provide enough 
data to control for such rating bias. However, our data showed that self-rated DQoL 
scales were higher correlated with self-rated than with carer-rated QoL-AD scores 
and not associated with performance tests of cognition (table 6).  
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Conclusion 
Our validation study revealed that the DQoL sufficiently measures the self-rated QoL 
of patients with mild to moderate dementia in the domains positive and negative af-
fect, and fairly assesses feelings of belongings and self-esteem. Researchers should 
consider that according to the Hierarchy Model of Needs in Dementia [14] the DQoL 
does not represent basic physiological and safety needs and insufficiently covers so-
cial contacts and enjoyment of activities. 
The bad fit of the five factor model substantiate the need of further research for the 
improvement of the DQoL in general. Our findings suggest the following precisions: 
1. The scale aesthetics should be renamed and restructured in order to cover the 
enjoyment of a broader range of activities. 
2. The scale feeling of belongings could be improved to cover the full domain of 
social contacts. 
3. The scale self esteem might be expanded with items fully representing needs 
of esteem and self-actualisation. 
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7 
General Discussion
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This research project intended to evaluate whether positive effects of complex psy-
chosocial interventions in dementia can be transferred from one country to another.  
Our randomised trial at seven German study sites revealed that a community occu-
pational therapy programme could not travel from the Dutch source to the target con-
text. A half year after baseline, the German active controlled study found in both 
groups a similar stabilisation on daily functioning and quality of life in patients and 
caregivers, while the Dutch trial detected significant differences between the interven-
tion and the waiting-control group after three months. Thus our main hypothesis that 
intensive occupational therapy would result in the patients’ better daily functioning 
than the routine care of one comprehensive consultation must be rejected. 
In order to exclude potential measurement bias, we carried out revalidation studies of 
three measurement instruments translated for this study. The posthoc validation of 
instruments measuring daily functioning and quality of life revealed some weak-
nesses in the structures of subscales but no essential measurement bias. 
Furthermore, we explored potential effect modifiers using an accompanying process 
evaluation. Effect modifications by study site effects, variations in treatment perform-
ance or systematic differences between experimental and control group in further 
medical resource utilisation during the treatment period could be excluded. However, 
compared to the Dutch original study our German patient sample with high daily func-
tioning and low potential for improvement at baseline, the impact of the active control 
group and a partial poor performance of treatment components may have diminished 
group differences in the primary outcome. 
 
 
Strengths and weaknesses 
 
The project plan had to be carried out in a challenging two years time frame with a 
fixed starting point in spring 2008, both set by the funding agency. Consequently, we 
had to start planning before the results of the Dutch pilot and main implementation 
study had been analysed.1 Thus we could not learn from the experience of how to 
transfer the mono-centre expert programme to the Dutch multi-centre routine care 
setting. Furthermore, it was not possible to involve clinical practitioners in the adapta-
tion of the COTiD manual to the local context as suggested in implementation re-
search.2 Moreover, the practical training in treatment skills after the introductory 
seminar during the pilot phase could not be supervised face-to-face but only by e-
mail and telephone. Also refreshment seminars after some months could not be of-
fered because of this tight schedule. But the COTiD demonstrated such large effect 
sizes in the primary outcome with Cohen’s d>2.0, that we reasonably hypothesised 
that at least moderate effects will be found despite variations in the treatment per-
formance potentially arising from less elaborated and adapted implementation strate-
gies. To control for such variations, we decided to perform a process evaluation as 
recommended in the guidance of the British Medical Research Council.3  
An ideal situation regarding measurement instruments in cross-national transfer is 
given, when assessments applied in the source country are also available in the tar-
get country and have already been fully validated within similar samples. Our re-
search framework differed from this ideal situation for three instruments. The 
Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group recommended a 
reasonable pragmatism for such cases.4 The authors differentiated four changes: (1) 
change in the content of an instrument, (2) in the mode of administration, (3) transla-
tion and (4) application to different patient population. Depending on the changes 
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made for the instrument, the Mayo group recommended revalidation strategies rang-
ing from (a) a focus group or patient interview to confirm content validity, (b) a test of 
the basic psychometric properties posthoc or (c) a comprehensive revalidation a pri-
ori to the outcome study. Because we had in our research project only the translation 
but no changes in the content, administration modus or patient population, we de-
cided for posthoc confirmation of the main psychometric properties of the IDDD, 
PRPP and DQoL. 
The study’s strengths were the exclusion of measurement bias and modifying effects, 
the conservative power calculation to assure the detection even of small effects and 
the elaborated design for a pragmatic multi-centre trial according to the recommenda-
tion of the CONSORT and PRACTIHCS groups.5 
 
 
Comparison  
 
In the international literature, we found two high quality studies sufficiently reporting 
methods and results relevant to our findings on cross-national transfer in dementia.  
The only transfer trial on community occupational therapy was a replication and 
the extension of the pilot study in Philadelphia, USA.6 7 Both trials were carried out by 
the same research team at the same study site with the same five interventionists 
plus one novice in the main study. The samples of the pilot and the main study dif-
fered slightly in MMSE at baseline (11.6 vs. 13.4). Challenging behaviour could be 
reduced for about one third after 4 months treatment in both studies. However, while 
the waiting-control group in the pilot study did not improve, the active control treat-
ment in the main study had an effect comparable to the experimental treatment in 
both trials. These results support our finding that active control treatment can dimin-
ish group differences in a replica study, while a significant contrast occurred in the 
pilot with waiting-control group design. The therapists had the same study site con-
text and the same expertise in both studies. Consistently to that also in both trials, 
they could improve the patients’ engagement in activities and the caregivers’ skills. 
This congruence between interventionists’ expertise and improved outcome can in 
reverse support our finding that partial poor treatment performance may reduce out-
come. Furthermore, it is notably that Gitlin and colleagues did not report a replication 
of the positive effect on time of informal care, although this was an essential outcome 
of the pilot study.8 Differences in the socio-demographic sample characteristics might 
explain heterogeneous findings on this outcome. The pilot sample comprised 62 % of 
spouse carers, the replica sample only 38 %.  
Mittelman and colleagues transferred their carer counselling programme in dementia 
from the USA and tried to replicate the positive effects on carer’s depression and pa-
tient’s institutionalisation in a three-country randomised trial in the USA, UK and Aus-
tralia.9-13 They found in both studies a slight reduction of depressive symptoms, al-
though the intervention in the replica was shorter (3 instead of 4 months), less com-
prehensive (5 instead of 6 counselling sessions and no subsequent carer support 
groups) and not carried out by the same staff, whose expertise was not reported in 
detail. In both studies, the carers had minimal depressive symptoms at baseline with 
a score in the Beck Depression Inventory (BDI) of less than 11. A score of 14 indi-
cates the cut off for mild depression. In both studies, a small difference could be 
found between experimental and control group after 2 years. The extend was about 
1.5 points on the BDI score representing less than 3 % of scale range (0 to 63). The 
nearly one year delayed nursing home placement, which had been found in the origi-
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nal study as effect of carer counselling (p=0.02), could not be shown in the replica 
study, although follow-up period was more than 8 years in both studies.10-12 One rea-
son might be that patients in the replica study were somewhat less severely affected 
by dementia as indicated by a score of 4.4 on the Global Deterioration Scale com-
pared to a score around 5 in the original study.  
 
Considering our findings and transfer studies as mentioned above, three areas can 
be determined as possibly modifying the replication of effects. 
o Differences of study samples in baseline characteristics, which represent a 
reasonable potential for improvement. 
o The impact of differences in control intervention design. 
o The expertise of the therapeutic study staff as well as the identification of ac-
tive treatment components and the quality of its performance. 
 
 
Implication for research 
 
Cross-national transfer of complex psychosocial interventions based on evidence in a 
source country should be thoroughly prepared within the routine care context of the 
target country. The main challenges are the early adaptation of sampling criteria and 
the sound implementation of treatment modalities in the target context.  
The transferability of the source intervention should be checked a priori and system-
atically by assessing (1) whether effects in the source country have been shown in a 
multi-centre context or replicated in a second mono-centre trial at another study site 
and (2) whether significant quantitative associations have been found between a suf-
ficient performance of active treatment components and an improved outcome rea-
sonably explaining the mechanism of the treatment impact. In our project, the as-
sumed “mechanism” of positive effects was based on the Dutch case study revealing 
that a well structured physical environment with auditory or visual cues, a repetitive 
training of simplified and highly meaningful everyday tasks and an improved interac-
tion between caregiver and patient are the active components to improve the pa-
tient’s daily functioning.14 However, there was no study providing evidence that e.g. 
the number of cues, the frequency of training or the degree of improvement in inter-
action within a sufficient number of treatment cases was clearly associated with daily 
functioning after the intervention. The established concept of dose-effect-relation in 
drug trials might be adapted to behaviour change intervention research. Therefore 
reliable quantitative measures for the implementation of treatment components pro-
posed to be the active agents are to be developed and correlated to primary out-
comes.15 16  
 
 
Implication for practice  
 
Our research results may have three main implications for dementia care. (1) Inten-
sive community occupational therapy can be offered for patients with at least moder-
ate need for assistance in daily functioning. (2) Based on global international guide-
lines for dementia care, occupational therapy guidelines should be provided for each 
country specifically adapted to the target context, before treatment is regularly ap-
plied within routine care. (3) The intensity of treatment is to be determined depending 
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on the dementia stage, the needs of the patient, the capabilities of the caregiver and 
the progress under treatment.  
 
 
In summary: community occupational therapy in dementia as well as cross-national 
transfer research in complex psychosocial interventions are promising fields to im-
prove health care in Europe. Other translational research efforts will tell us over time 
what the efficacy and effectiveness of occupational therapy outside the initial re-
search setting may be.17 Funding agencies, interdisciplinary and international re-
search teams as well as providers of routine care should jointly prepare stepped re-
search lines, at best based on the new guidance for developing and evaluating com-
plex interventions18 19, which might also be extended by recommendations for cross-
national transfer.  
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Summary 
 
Dementia is syndrome primarily caused by chronic progressive diseases that result in 
deterioration of mental and physical capabilities, which in turn affects a person’s abil-
ity to function independently. The number of people with dementia is predicted to be 
16 million in the year 2050 in Europe.  
The deterioration of dementia patients’ daily functioning and their challenging behav-
iour is an increasing burden for their families and caregivers.  
Literature on the efficacy of interventions on everyday functioning in dementia sug-
gests that positive effects of currently available drugs (i.e. acethylcolinesterase inhibi-
tors and memantine) on the activities of daily living are small and that high quality 
multi-centre randomised trials on the effects of psychosocial interventions are miss-
ing. 
 
Purpose: The aim of the research described in this thesis was to determine whether 
an evidence-based Dutch home visit programme in dementia still has positive effects 
on patients’ daily functioning when newly introduced therapists apply it within the 
German routine care context.  
 
Method: We conducted a pragmatic randomised controlled trial at seven German 
study memory clinics. The study also focussed on exploring bias possibly introduced 
by study site effects or variations in the treatment performance caused by translation 
from a Dutch to a German context. This part of the research was carried out in exten-
sive cross-national process evaluation. In the whole process of copying the interven-
tion to Germany, we aimed to exclude measurement bias by trans-cultural validation 
efforts of the three main measurements (IDDD, PRPP and DQoL, see below), whose 
psychometric properties had not yet been investigated within German samples. 
 
Participants: 141 patients with mild to moderate Alzheimer's disease or mixed type 
of Alzheimer’s disease with vascular lesions, living in the community, with their pri-
mary carer available to take part in the study, and without severe depression or be-
havioural symptoms, were randomised to the experimental (N=71) and control group 
(N=70). Data for the 54 and 50 participants who were able to complete the study 
were analysed.  
 
Intervention and control:  
14 German occupational therapists (OTs) were trained in the occupational therapy 
intervention by using the translated treatment manual, watching videos and having 
role plays with feedback and group discussion. In the intervention, OTs spent about 
20 hours per patient and caregiver for a full treatment series including 10 treatment 
sessions, travel, reports and a multidisciplinary briefing. Sessions of 1 hour’s duration 
were held over five weeks at each patient’s home. The occupational therapist ex-
plored the patient’s preferences and performance of daily activities as well as the 
possibilities of modifying the patient’s home and improving the interaction between 
carer and patient. After selecting the most meaningful activities, the occupational 
therapist defined, together with the patient and the carer, more effective compensa-
tory and environmental strategies to adapt both the environment and the selected 
activities to the patient's habits and cognitive abilities. Patient and carer were taught 
how to use these suggested adaptations. 
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The control group received 1 h of occupation therapy instruction at the patient’s 
home conducted by the same study interventionists. The semistructured control con-
sultation was an explanation of 30 min of an OT leaflet and a talk of 30 min on indi-
vidual problems that arose from the patient’s and carer's needs. 
 
Outcome measures: The primary outcome was the patients’ daily functioning meas-
ured with the Interview of Deterioration in Daily activities in Dementia (IDDD) and the 
Perceive, Recall, Plan and Perform System of Task Analysis (PRPP). Secondary 
outcomes such as the Dementia Quality of Life instrument (DQoL) were also used. 
Assessments were at baseline, 6, 16, and 26 weeks, with a postal assessment at 52 
weeks. 
 
Results: The positive effects of the community occupational therapy programme 
found in The Netherlands could not be confirmed in the German target context. In the 
Dutch and German groups, a similar stabilisation on daily functioning and quality of 
life in patients and caregivers was found a half year after baseline.  
The posthoc validation of instruments measuring daily functioning and quality of life 
revealed no essential measurement bias. Effect modifications by study site effects, 
variations in treatment performance, or group differences in medical resource utilisa-
tion could be excluded.  
Compared to the Dutch study, the German patient sample showed a better daily 
functioning and therefore lower potential for improvement at baseline. The impact of 
this still rather active patient group and a partial poor performance of treatment com-
ponents may have caused the lack of positive effects in the primary outcome. 
 
Implications for practice: Intensive community occupational therapy might be of-
fered when patients have at least moderate need for assistance in daily functioning. 
The treatment should be based on guidelines specifically adapted to the target con-
text. The intensity of the treatment is to be determined depending on the dementia 
stage, the patient’s needs, the caregiver’s capabilities and the progress under treat-
ment.  
 
Implications for future research: In future research aiming at cross-national trans-
fer of (psychosocial) interventions, the transferability of such, often complex, interven-
tions should be checked a priori by assessing (1) whether effects in the source coun-
try has been shown in a multi-centre context or replicated in a second mono-centre 
trial at another study site and (2) whether significant quantitative associations have 
been found between intensity of performance of active treatment components and an 
improved outcome reasonably explaining the mechanism of the treatment impact. 
Finally, it should be safeguarded that the intervention can be targeted at a patient 
population with similar characteristics as in the original intervention. Other transla-
tional research efforts will tell us over time what the efficacy and effectiveness of oc-
cupational therapy outside the initial research setting may be. 
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Samenvatting 
 
Introductie: Dementie wordt met name verzoorzaakt door chronisch progressieve 
aandoeningen, die de psychische en lichamelijke functies aantasten en het 
zelfstandig functioneren beperken. In 2050 verwacht men dat in Europa 16 miljoen 
mensen lijden aan dementie.  
De toenemende beperkingen in het dagelijks functioneren van dementie patiënten 
veroorzaken ook een steeds groter wordende belasting voor hun naasten en 
mantelzorgers. 
De literatuur over de werkzaamheid van interventies ter verbetering van het dagelijks 
functioneren laat zien dat de positieve effecten van de thans beschikbare 
geneesmiddelen (de zogenaamde acethylcholinesterase remmers en memantine) op 
het algemeen dagelijks functioneren beperkt zijn en dat er eigenlijk vrijwel geen multi-
centrum studies van goede kwaliteit zijn over psychosociale interventies.  
 
Doel: het doel van het onderzoek beschreven in dit proefschrift was na te gaan of 
een bestaand en in Nederland effectief gebleken ergotherapie programma ter 
behandeling en instructie van dementia patiënten thuis, ook werkzaam is wanneer 
het wordt uitgevoerd in een vergelijkbare context in Duitsland, door ergotherapeuten 
die specifiek ten behoeve van de studie in de interventie zijn opgeleid. 
 
Methode: We voerden een pragmatische gerandomiseerde en gecontrolleerde 
studie uit in zeven Duitse geheugenklinieken.  
De studie was er met name ook op gericht om na te gaan of en waardoor verschil in 
setting of in uitvoering van de interventie verschillen in effect zou kunnen 
verzoorzken bij deze buitenlandse uitvoering van de ergotherapie interventie. Dit deel 
van de studie werd uitgevoerd met een uitgebreide procesanalyse. 
Bij de vertaling van de interventie en de evaluatie ervan van Nederland naar 
Duitsland werd zorg gedragen voor validering van de drie belangrijkste 
meetinstrumenten die voor de studie waren vertaald in het Duits (IDDD, PRPP en 
DQoL, zie verder), en werden de psychometrische eigenschappen hiervan 
onderzocht. Dit was voor deze instrumenten nog niet eerder gedocumenteerd in een 
Duitstalige context. 
 
Deelnemers: Er namen 141 patiënten met lichte tot matige ernst van dementie deel 
aan de studie. De patiënten konden zowel lijden aande ziekte van Alzheimer, als aan 
een combinatie van Alzheimer type pathologie en vaatschade. Alle patienten 
woonden nog thuis en hadden een mantelzorger die wilde deelnemen aan de studie. 
Ze hadden geen ernstig depressieve kenmerken, noch gedragsproblemen. De 141 
patiënten werder gerandomiseerd over een interventie (N=71) en een controlegroep 
(N=70). We konden uiteindelijk de gegevens analyseren van respectievelijk de 54 en 
50 patiënten die de gehele studie voltooiden. 
 
Interventie: 14 Duitse ergotherapeuten werden getraind in de interventie door het 
leren gebruiken van de vertaalde handleiding voor de interventie, het bekijken van 
instructievideo’s en het uitvoeren van rollenspelen met feedback en 
groepsdiscussies. In de interventiegroep werd gemiddeld 20 uur per patient en 
mantelzorger besteed aan een volledige serie van 10 behandelingen, inclusief 
reistijd, rapportage en een multidisciplnair overleg. 
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De controlegroep kreeg 1 uur ergotherapie thuis, door dezelfde ergotherapeuten. Dit 
uur bestond voor de helft uit instructie aan de hand van een ergotherapie folder en 
voor de helft uit een inventarisatie van de problemen van de patient en mantelzorger. 
 
Uitkomstmaten: De primaire uitkomstmaten van de studie waren een instrument 
genaamd “Interview van het Dagelijks leven met Dementia” (IDDD in het Engels) en 
de zorgenaamde “Perceive, Recall, Plan and Perform System of Task Analysis” 
(PRPP). Secundaire uitkomstmaten zoals de kwaliteit van leven (DQoL: Dementia 
Quality of Life Instrumen) werder ook gemeten. De metingen warden afgenomen bij 
de start van de studie en na 6, 16 en 26 weken, met een laatste schriftelijke afname 
na 52 weken. 
 
Resultaten: De positieve effecten van de ergotherapie interventie thuis zoals 
behaald in de Nederlandse context konden niet worden bevestigd in de Duitse 
interventie. In Nederlandse en Duitse groepen werd echter wel een gelijkaardige 
stabilisatie van het dagelijks functioneren en de kwaliteit van leven gezien van de 
patiënten en mantelzorgers een half jaar na start van de studie. 
De posthoc validering van de vertaalde meetinstrumenten in Duitsland maakte een 
vertekening door deze vertaling onwaarschijnlijk. 
De vermindering van dit resultaat van de interventie door een eventueel verschil 
tussen de verschillende deelnemende instellingen in Duitsland, of door variatie in het 
geven van de ergotherapie interventie, of het gebruik van andere hulpmiddelen kon 
onwaarschijnlijk worden gemaakt in aanvullende analyses. 
Vergeleken met de Nederlandse populatie toonde de Duitse groep patiënten bij wie 
de studie was uitgevoerd echter wel een wat beter niveau van algemeen 
functioneren bij start van de interventie, waardoor zij mogelijk minder goed konden 
verbeteren. Dit verschil in functioneren en een mogelijk minder goed uitvoeren van 
onderdelen van de interventie, met een actieve controle groep waarin ook een uur 
ergotherapie werd gegeven, zou samen het verschil in werkzaamheid tussen de 
Nederlandse en Duitse uitvoering van de ergotherapie thuis bij dementie patiënten 
kunnen verklaren. 
 
Betekenis voor de praktijk: Intensieve ergotherapie thuis zou het beste 
aangeboden kunnen worden aan dementiepatiënten met tenminste een matig 
ernstige noodzaak van ondersteuning in het dagelijks functioneren. De behandeling 
zou moeten worden gebaseerd op richtlijnen die specifiek zijn geschreven voor de 
(land-specifieke) context waarin de interventie wordt uitgevoerd. De intensiteit van de 
bahandeling moet daarbij worden aangepast aan de ernst van de dementie, de 
vragen en problemen van de patient, de mogelijkheden van de mantelzorger en de 
mate waarin men vooruitgang ziet tijdens de behandeling. 
 
Betekenis voor verder onderzoek: In toekomstig onderzoek waarin men een 
(psychosociale) interventie wil toepassen in een ander land zou met een aantal 
lessen uit dit onderzoek rekening moeten houden: 
1. Zijn de effecten van de interventie die men wil toepassen ook al aangetoond in 
multi-centre onderzoek of is er tenminste replicatie in het land van herkomst 
van de interventie uitgevoerd? 
2. Zijn er al gegevens die een dosis-effect relatie van de intensiteit van de 
uitgevoerde interventie met de grootte van het effect aannemelijk maken? 
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3. Kan de interventie bij een voldoende gelijkaardige populatie worden 
uitgevoerd bij translatie naar het andere land? 
Andere translaties zullen mettertijd leren in hoeverre ergotherapie thuis effectief is 
buiten de initiële research setting. 
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